<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Public Health</journal-id><journal-id journal-id-type="iso-abbrev">BMC Public Health</journal-id><journal-title-group><journal-title>BMC Public Health</journal-title></journal-title-group><issn pub-type="epub">1471-2458</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5796301</article-id><article-id pub-id-type="publisher-id">5092</article-id><article-id pub-id-type="doi">10.1186/s12889-018-5092-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Interventions to reduce post-acute consequences of diarrheal disease in children: a systematic review</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Pavlinac</surname><given-names>Patricia B.</given-names></name><address><email>ppav@uw.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Brander</surname><given-names>Rebecca L.</given-names></name><address><email>rbrander@uw.edu</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Atlas</surname><given-names>Hannah E.</given-names></name><address><email>hatlas@uw.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>John-Stewart</surname><given-names>Grace C.</given-names></name><address><email>gjohn@uw.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Denno</surname><given-names>Donna M.</given-names></name><address><email>ddenno@uw.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Walson</surname><given-names>Judd L.</given-names></name><address><email>walson@uw.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000000122986657</institution-id><institution-id institution-id-type="GRID">grid.34477.33</institution-id><institution>Department of Global Health, </institution><institution>University of Washington, </institution></institution-wrap>Seattle, WA USA </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000000122986657</institution-id><institution-id institution-id-type="GRID">grid.34477.33</institution-id><institution>Department of Epidemiology, </institution><institution>University of Washington, </institution></institution-wrap>Seattle, WA USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000000122986657</institution-id><institution-id institution-id-type="GRID">grid.34477.33</institution-id><institution>Department of Pediatrics, </institution><institution>University of Washington, </institution></institution-wrap>Seattle, WA USA </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000000122986657</institution-id><institution-id institution-id-type="GRID">grid.34477.33</institution-id><institution>Department of Medicine (Infectious Disease), </institution><institution>University of Washington, </institution></institution-wrap>Seattle, WA USA </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000000122986657</institution-id><institution-id institution-id-type="GRID">grid.34477.33</institution-id><institution>Department of Health Services, </institution><institution>University of Washington, </institution></institution-wrap>Seattle, WA USA </aff></contrib-group><pub-date pub-type="epub"><day>1</day><month>2</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>2</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>18</volume><elocation-id>208</elocation-id><history><date date-type="received"><day>7</day><month>8</month><year>2017</year></date><date date-type="accepted"><day>17</day><month>1</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2018</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Although acute diarrhea often leads to acute dehydration and electrolyte imbalance, children with diarrhea also suffer long term morbidity, including recurrent or prolonged diarrhea, loss of weight, and linear growth faltering. They are also&#x000a0;at increased risk of post-acute mortality. The objective of this systematic review was to identify interventions that address these longer term consequences of diarrhea.</p></sec><sec><title>Methods</title><p id="Par2">We searched Medline for randomized controlled trials (RCTs) of interventions conducted in low- and middle-income countries,&#x000a0;published between 1980 and 2016 that included children under 15&#x000a0;years of age with diarrhea and follow-up of at least 7&#x000a0;days. Effect measures were summarized by intervention. PRISMA guidelines were followed.</p></sec><sec><title>Results</title><p id="Par3">Among 314 otherwise eligible RCTs, 65% were excluded because follow-up did not extend beyond 7&#x000a0;days. Forty-six trials were included, the majority of which (59%) were conducted in Southeast Asia (41% in Bangladesh alone). Most studies were small, 76% included less than 200 participants. Interventions included: therapeutic zinc alone (28.3%) or in combination with vitamin A (4.3%), high protein diets (19.6%), probiotics (10.9%), lactose free diets (10.9%), oral rehydration solution (ORS) formulations (8.7%), dietary supplements (6.5%), other dietary interventions (6.5%), and antimicrobials (4.3%). Prolonged or recurrent diarrhea was the most commonly reported outcome, and was assessed in ORS, probiotic, vitamin A, and zinc trials with&#x000a0;no consistent benefit observed. Seven trials evaluated mortality, with follow-up times ranging from 8&#x000a0;days to 2&#x000a0;years. Only a single trial found a mortality benefit (therapeutic zinc). There were mixed results for dietary interventions affecting growth and diarrhea outcomes in the post-acute period.</p></sec><sec><title>Conclusion</title><p id="Par4">Despite the significant post-acute mortality and morbidity associated with diarrheal episodes, there is sparse evidence evaluating the effects of interventions to decrease these sequelae. Adequately powered trials with extended follow-up are needed to identify effective interventions to prevent post-acute diarrhea outcomes.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (10.1186/s12889-018-5092-7) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Pediatric diarrhea management</kwd><kwd>Child growth</kwd><kwd>Diarrhea interventions</kwd><kwd>Child mortality</kwd><kwd>Long-term sequelae of diarrhea</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000865</institution-id><institution>Bill and Melinda Gates Foundation</institution></institution-wrap></funding-source><award-id>OPP1132140</award-id><award-id>OPP1131320</award-id><principal-award-recipient><name><surname>Pavlinac</surname><given-names>Patricia B.</given-names></name><name><surname>Walson</surname><given-names>Judd L.</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P30 AI027757</award-id><award-id>K24- HD054314</award-id><principal-award-recipient><name><surname>John-Stewart</surname><given-names>Grace C.</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par19">Close to 600,000 children die each year from diarrheal disease, the majority in low- and middle-income countries (LMICs) [<xref ref-type="bibr" rid="CR1">1</xref>]. Children with a single episode of moderate-to-severe diarrhea (MSD) experience an 8.5-fold higher risk of dying in the 60-days following the episode compared to age-matched healthy children, despite standard diarrhea case management including rehydration and zinc [<xref ref-type="bibr" rid="CR2">2</xref>]. A verbal autopsy study conducted in 7 LMICs found that 55.6% of pediatric diarrhea deaths occurred in children who had been rehydrated [<xref ref-type="bibr" rid="CR3">3</xref>]. Although rehydration and zinc have resulted in millions of lives saved from diarrhea,&#x000a0;they&#x000a0;may be insufficient to prevent all diarrhea-associated mortality.&#x000a0;</p><p id="Par20">The consequences of diarrhea extend beyond acute dehydration and electrolyte imbalance. Over two-thirds of deaths associated with diarrhea occur more than 7&#x000a0;days after presentation [<xref ref-type="bibr" rid="CR2">2</xref>]. An episode of MSD is also associated with subsequent loss of length/height-for-age z-score (LAZ/HAZ), a measure of chronic malnutrition [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Undernutrition is linked to half of all diarrhea-associated mortality and is associated with other long-term outcomes including reduced school attendance and future earning potential [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par21">While mortality from diarrheal diseases has declined since the 1990&#x02019;s, incidence rates have remained stable&#x000a0;and there is increasing recognition of the morbidity, disability, and long-term consequences associated with diarrhea. We conducted a systematic review to identify and summarize randomized controlled trials (RCTs) of diarrhea management interventions to determine effects on death, anthropometric status, and prevalence and incidence of diarrhea in the post-acute period.</p></sec><sec id="Sec2"><title>Methods</title><p id="Par22">The systematic review followed PRISMA guidelines. We searched Medline for English-language RCTs published between January 1, 1980 and October 31, 2016 conducted among children under 15&#x000a0;years of age presenting with diarrhea (all diarrhea definitions accepted) at the time of treatment. Specifically, we searched for trials evaluating 1 of the following interventions: antiemetics, antibiotics, antiprotozoals, antisecretories, dietary supplements, intravenous hydration therapy, oral rehydration therapy, probiotics, prebiotics, lactose replacement, and therapeutic zinc. These interventions were chosen based on consultation with experts in the field. The search terms used were as follows:</p><p id="Par23">((((((((((((antibiotic OR antiinfective OR anti-infective OR antimicrobial OR antiparasitic OR anti-parasitic OR antiprotozoa* OR anti-protozoa* OR ciprofloxacin OR erythromycin OR metronidazole OR antiemetic* OR anti-emetic OR anti-vomit* OR antidiarrheal OR secretoinhibit* OR antipropulsive OR antisecret* OR anti-secret OR breast* OR formula* OR milk OR wean* OR treatment OR management OR &#x0201c;amylose maize starch&#x0201d; OR hams OR lams OR prebiotics OR &#x0201c;resistant starch&#x0201d; OR bifidobacter* OR lactobacill* OR lactococc* OR microbi* OR probiotic* OR fluid OR intravenous OR IV OR ORS OR &#x0201c;oral rehydration salt&#x0201d; OR ORT OR &#x0201c;oral rehydration therapy&#x0201d; OR polymer OR rehydration OR minerals OR zinc)))) AND (&#x0201c;1980/01/01&#x0201d;[Date - Publication]: &#x0201c;2016/10/31&#x0201d;[Date - Publication])) AND (((&#x0201c;bloody stool&#x0201d; OR diarrh* OR dysentery OR gastroenterit*))))) AND ((((clinical trial) OR placebo-controlled trial) OR randomized controlled trial))))) NOT cancer) NOT antibiotic associated diarrhea)</p><p id="Par24">Filters: Clinical Trial; Humans; English; Child: birth-18&#x000a0;years</p><p id="Par25">We excluded studies in 2 steps. The first step aimed to exclude trials that did not address the populations or interventions of interest. Specifically, studies conducted in high-income countries (as defined by the World Bank as of June 2015) [<xref ref-type="bibr" rid="CR7">7</xref>], those that did not include children with diarrhea at enrollment, utilized a design other than an RCT, or did not present individual-level outcome data were excluded in the first round. The second round excluded trials with insufficient follow up (less than 7&#x000a0;days) and those that lacked outcome data on mortality, length/height, LAZ/HAZ, weight, weight-for-age z-score (WAZ), weight-for-height z-score (WHZ), mid upper arm circumference (MUAC), or diarrhea presence at a pre-specified follow-up point &#x02265;7&#x000a0;days after enrollment. Although weight may be misclassified during diarrhea illness due to fluid loss, in the context of an RCT, groups were assumed to be balanced with regard to hydration status. Therefore, weight, WAZ, and WHZ were considered valid outcomes. Diarrhea duration (other than presence of diarrhea at a pre-specified time point beyond 7-days) and stool output were not included as outcomes because they were considered intermediate to the outcomes of interest in this review.</p><p id="Par26">All titles and abstracts were screened by&#x000a0;2 reviewers (PBP and HEA) and abstracts of agreed-upon titles were examined for inclusion. Full texts of agreed-upon abstracts were reviewed for inclusion by RLB and HEA with final input from PBP. The following study-specific information was abstracted from included trials: intervention, control group, population, dates of enrollment, sample size, duration of follow up, reported outcomes, and data on effect sizes of relevant outcomes, and associated confidence intervals (CIs). Details on data abstraction and calculations are provided in the supplementary material for this manuscript (Additional file <xref rid="MOESM1" ref-type="media">1</xref>).</p><p id="Par27">A modified Grading of Recommendations Assessment Development and Evaluation (GRADE) approach was developed to assess study design elements including sample size, number of participants lost to follow up or withdrawn from the study, and blinding and allocation concealment methods to evaluate the quality of studies. We did not assess the GRADE elements of directness or consistency, as these elements are specific to results reported within a given intervention and outcome category and this review assessed multiple interventions and outcomes. All trials started with 4&#x000a0;points because all were randomized controlled trials and 1 point was deducted for each of the following elements: sparse data (&#x0003c;&#x02009;200 trial participants), &#x0003e;&#x02009;5% loss-to-follow-up or withdraws, or lack of double-blinding. Reviewers (HA and RB) applied the modified GRADE system included in this review and categorized each study as high quality (4 points), moderate (3 points), low (2 points), or very low (1 point) based on their final score. In addition to the elements required for GRADE, from included trials we abstracted whether or not a primary endpoint was declared (and whether the primary endpoint was 1 of the endpoints included in this review) and any mention of power calculations for included outcomes.</p></sec><sec id="Sec3"><title>Results</title><p id="Par28">The Medline search returned 2815 titles, of which 693 abstracts and 432 full texts were reviewed, and 385 excluded based on full-text review (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Among the 314 studies that were eligible based on study location, design, and population (included based on first exclusion step), most (205 [65.2%]) were excluded for failure to meet our criteria for length of follow up (7&#x000a0;days or more) and 51 (16.2%) were excluded because no outcomes of interest were reported in the second exclusion phase.<fig id="Fig1"><label>Fig. 1</label><caption><p>Flow chart of included trials of diarrhea management interventions</p></caption><graphic xlink:href="12889_2018_5092_Fig1_HTML" id="MO1"/></fig></p><p id="Par29">Forty-six trials were included in this review, the majority (27 studies [58.7%]) of which were conducted in the WHO-classified Southeast Asia region [<xref ref-type="bibr" rid="CR8">8</xref>&#x02013;<xref ref-type="bibr" rid="CR34">34</xref>], with 19 (70.4%) conducted in Bangladesh alone (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Seven studies (15.2%) were conducted in the Americas [<xref ref-type="bibr" rid="CR35">35</xref>&#x02013;<xref ref-type="bibr" rid="CR41">41</xref>], 7 studies (15.2%) reported data from Africa [<xref ref-type="bibr" rid="CR42">42</xref>&#x02013;<xref ref-type="bibr" rid="CR48">48</xref>], 2 from the Eastern Mediterranean (Pakistan) [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>] and 2 from Europe (Turkey) [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. One study was conducted in 3 countries (Ethiopia, Pakistan, and India) [<xref ref-type="bibr" rid="CR53">53</xref>]. The majority of the trials were conducted in inpatient settings (35 studies, 76.1%). Five (10.9%) trials were community-based, and the remaining 6 (13.0%) were conducted in outpatient settings. The most common interventions included therapeutic zinc (15 studies [32.6%], 2 of which was assessed in the same trial as vitamin A), and high protein diets (9 studies [19.6%]). Probiotics were assessed in 5 studies (10.9%), and 5 trials evaluated lactose-free diets (10.9%). Four were trials of ORS formulations (8.7%), and 3 (6.5%) trials evaluated dietary supplements, including dietary fiber (2 studies), and glutamine (1 study). Three (6.5%) trials were of other dietary interventions, a semi-elemental diet and 2, 3-armed trials evaluated ready-to-use therapeutic food (RUTF) or micronutrient powder. Only 2 (4.3%) of the trials that fit our inclusion criteria evaluated antimicrobial treatments (1 antibiotic and 1 antiprotozoal). We did not find any trials of intravenous (IV) rehydration, antisecretory agents, or antiemetic agents that met our inclusion criteria. The sample size of included studies ranged from 18 to 8070 and only 11 (23.9%) of the 46 trials included more than 200 participants (1 ORS, 2 probiotic, 2 RUTF/micronutrient, 1 vitamin A&#x02009;+&#x02009;zinc, and 5 zinc trials). Just over half of included trials (52.2%) reported power/sample size calculations, the majority of which (11 [48%] of the 23) were powered for the outcome of diarrhea duration/stool output, outcomes not included in this systematic review.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Characteristics of included studies</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Reference [Ref #]</th><th>Country</th><th>Population</th><th>Intervention</th><th>Comparator</th><th>Number with follow up data</th><th>Pre-specified follow up time</th><th>Relevant outcomes measured and power<sup>i</sup></th><th>Modified GRADE score</th></tr></thead><tbody><tr><td colspan="9">Antimicrobial Intervention</td></tr><tr><td>&#x02003;Gilman 1980 [<xref ref-type="bibr" rid="CR8">8</xref>]</td><td>Bangladesh</td><td>Inpatient adults and children with blood, pus cells, and mucus in stool, 4 or more stools/day, and culture-confirmed <italic>Shigella</italic> infection</td><td>Low-dose ampicillin (50&#x000a0;mg/kg/day)</td><td>High-dose ampicillin (150&#x000a0;mg/kg/day)</td><td>56 children</td><td>21&#x000a0;days</td><td>Mortality (power/sample size calculations not reported)</td><td>Very low<sup>&#x003a9;,&#x003a6;&#x003a8;</sup></td></tr><tr><td>&#x02003;Amadi 2002 [<xref ref-type="bibr" rid="CR42">42</xref>]</td><td>Zambia</td><td>Inpatient children 12&#x02013;85 mo with diarrhea (at least 3 stools per day that take the shape of a container or can be poured) and <italic>Cryptosporidium</italic> oocysts</td><td>5&#x000a0;mL of 20&#x000a0;g/L nitazoxanide oral suspension, twice daily for 3&#x000a0;days</td><td>Placebo</td><td>96</td><td>8&#x000a0;days</td><td>Mortality (powered for outcome of clinical response)</td><td>Moderate<sup>&#x003a9;</sup></td></tr><tr><td colspan="9">Dietary Supplements</td></tr><tr><td>&#x02003;Alam 2000 [<xref ref-type="bibr" rid="CR26">26</xref>]</td><td>Bangladesh</td><td>Inpatient males 4&#x02013;18 mo with acute non-dysenteric diarrhea</td><td>WHO ORS with dietary fiber(20&#x000a0;g/L Benefiber&#x000ae;)</td><td>Standard WHO-ORS</td><td>150</td><td>7&#x000a0;days</td><td>Weight gain at day 7 from enrollment (powered for the outcome of stool output)</td><td>Moderate<sup>&#x003a9;</sup></td></tr><tr><td>&#x02003;Rabbani 2001 [<xref ref-type="bibr" rid="CR15">15</xref>]</td><td>Bangladesh</td><td>Severely malnourished (&#x0003c;&#x02009; 60% NCHS standard), inpatient male infants 5&#x02013;12 mo with persistent diarrhea (&#x0003e;&#x02009;3 loose stools/day for 14&#x000a0;days), treated with ciprofloxacin</td><td>Rice-based diet with dietary fiber (250&#x000a0;m/L cooked, green banana, 7&#x000a0;days; or rice-based diet with 1&#x000a0;g/kg to 8&#x000a0;g/kg of pectin supplement) 7&#x000a0;days</td><td>Calorically equivalent control diet: rice-based diet only, 7&#x000a0;days</td><td>62</td><td>At least 7&#x000a0;days, or until end of diarrhea</td><td>Proportions recovered from diarrhea [formed stool] at days 7, 8, 9, and 10 (powered for outcome of diarrhea recovery duration)</td><td>Moderate<sup>&#x003a9;</sup></td></tr><tr><td>&#x02003;Yalcin 2004 [<xref ref-type="bibr" rid="CR51">51</xref>]</td><td>Turkey</td><td>Inpatient children 6&#x02013;24 mo with acute diarrhea</td><td>Glutamine supplement - 0.3&#x000a0;g/kg/day, for 7&#x000a0;days</td><td>Placebo</td><td>143</td><td>3&#x000a0;months</td><td>Weight gain at day 30, 60, and 90 from enrollment (powered for the outcome of diarrhea duration)</td><td>Low<sup>&#x003a9;, &#x003d1;</sup></td></tr><tr><td colspan="9">High Protein Diets</td></tr><tr><td>&#x02003;Datta 1990 [<xref ref-type="bibr" rid="CR9">9</xref>]</td><td>India</td><td>Inpatient children under 5 y/o with acute dysentery (visible blood and mucus in stools), treated with nalidixic acid</td><td>Extra servings of milk (30% of total daily caloric requirements), in addition to standard hospital diet</td><td>Standard hospital diet</td><td>96</td><td>15&#x000a0;days</td><td>Weight and MUAC at day 15 (power/sample size calculations not reported)</td><td>Very low<sup>&#x003a9;, &#x003a6;, &#x003d1;&#x003a8;</sup></td></tr><tr><td>&#x02003;Kabir 1992 [<xref ref-type="bibr" rid="CR10">10</xref>]</td><td>Bangladesh</td><td>Inpatient children 2&#x02013;4 y/o with culture-confirmed <italic>Shigella</italic> dysentery, treated with nalidixic acid or other microbial</td><td>High protein diet (15% of total energy from protein), 21&#x000a0;days</td><td>Standard diet (7.5% of total energy from protein), 21&#x000a0;days</td><td>22</td><td>21&#x000a0;days</td><td>Change in weight, height, WAZ, WHZ, HAZ, MUAC, and triceps skinfold thickness at day 21 from admission (power/sample size calculations not reported)</td><td>Very low<sup>&#x003a9;, &#x003a6;, &#x003d1;&#x003a8;</sup></td></tr><tr><td>&#x02003;Kabir 1993 [<xref ref-type="bibr" rid="CR11">11</xref>]</td><td>Bangladesh</td><td>Outpatient children 2&#x02013;5 y/o with acute diarrhea and culture-confirmed <italic>Shigella</italic> spp., treated with nalidixic acid or pivmecillinam</td><td>High protein diet (15% of total energy from protein), 21&#x000a0;days</td><td>Standard diet (7.5% of total energy from protein), 21&#x000a0;days</td><td>69</td><td>21&#x000a0;days</td><td>Change in WHZ, WAZ, and HAZ at day 21 from admission (power/sample size calculations not reported)</td><td>Very low<sup>&#x003a9;, &#x003a6;, &#x003d1;&#x003a8;</sup></td></tr><tr><td>&#x02003;Mazumder 1997 [<xref ref-type="bibr" rid="CR12">12</xref>]</td><td>Bangladesh</td><td>Malnourished (&#x0003c;&#x02009;80% NCHS median), inpatient children 12&#x02013;48 mo with bloody or bloody mucoid diarrhea and culture-confirmed <italic>Shigella</italic>, treated with nalidixic acid</td><td>High calorie and high protein diet, 4960&#x000a0;kJ/l for 10&#x000a0;days</td><td>Standard hospital diet, 2480&#x000a0;kJ/l for 10&#x000a0;days</td><td>75</td><td>40&#x000a0;days</td><td>Percent change in WAZ and WHZ at 10, and 40 from admission (power/sample size calculations not reported)</td><td>Low<sup>&#x003a9;, &#x003a6;, &#x003a8;</sup></td></tr><tr><td>&#x02003;Nurko 1997 [<xref ref-type="bibr" rid="CR36">36</xref>]</td><td>Mexico</td><td>Inpatient children 3&#x02013;36 mo with persistent diarrhea (3 or more loose stools/day for 14&#x000a0;days or longer) and third-degree malnutrition (&#x0003c;&#x02009;60% NCHS median), treated with TMP-SMX or metronidazole</td><td>High protein diet (2 groups: chicken-based diet, or soy-based diet)<sup>ii</sup></td><td>Standard cultural dietary treatment for diarrhea (elemental diet or &#x0201c;Vivonex&#x0201d;)</td><td>41</td><td>16&#x000a0;days minimum</td><td>Weight at end of intervention and at discharge; proportion with nutritional recovery<sup>iii</sup> at end of intervention (powered for outcome of diarrhea duration)</td><td>Very low <sup>&#x003a9;, &#x003d1;, &#x003a8;</sup></td></tr><tr><td>&#x02003;Kabir 1998 [<xref ref-type="bibr" rid="CR13">13</xref>]</td><td>Bangladesh</td><td>Inpatient children 2&#x02013;60 mo with acute bloody mucoid diarrhea, treated with nalidixic acid or pivmecillinam</td><td>High protein diet (15% of total energy from protein), 21&#x000a0;days</td><td>Standard protein diet (7.5% of total energy from protein), 21&#x000a0;days</td><td>59</td><td>6&#x000a0;months post- intervention</td><td>Change in weight, height, WHZ, WAZ, and HAZ at 6&#x000a0;months compared to post-intervention measurements (power/sample size calculations not reported)</td><td>Very low <sup>&#x003a9;, &#x003a6;, &#x003d1;, &#x003a8;</sup></td></tr><tr><td>&#x02003;Mazumder 2000 [<xref ref-type="bibr" rid="CR14">14</xref>]</td><td>Bangladesh</td><td>Malnourished (&#x0003c;&#x02009; 80% of NCHS median) inpatient children 12&#x02013;48 mo with acute bloody or mucoid diarrhea, treated with nalidixic acid of pivmecillinim</td><td>High calorie &#x00026; protein milk-cereal formula (4960&#x000a0;kJ/l), 10&#x000a0;days</td><td>Control milk-cereal formula (2480&#x000a0;kJ/l), 10&#x000a0;days</td><td>75</td><td>10&#x000a0;days</td><td>Percent change in WAZ at day 10, compared to admission WAZ (power/sample size calculations not reported)</td><td>Very low<sup>&#x003a9;, &#x003d1;, &#x003a8;</sup></td></tr><tr><td>&#x02003;Valentiner-Branth 2001 [<xref ref-type="bibr" rid="CR43">43</xref>]</td><td>Guinnea-Bissau</td><td>Community-based children under 3 y/o with persistent diarrhea per mother&#x02019;s report</td><td>Counseling on the importance of breastfeeding and of a nutritious diet, and a high protein millet gruel with a multivitamin tablet (including zinc), until the end of a 7&#x000a0;day period without diarrhea</td><td>Counseling on the importance of breastfeeding and of a nutritious diet</td><td>101</td><td>9&#x000a0;months</td><td>Difference in knee-heel length, height and weight at end of intervention and day 90, compared to admission measurements (powered for outcome of diarrhea duration)</td><td>Very low<sup>&#x003a9;, &#x003a6;, &#x003a8;</sup></td></tr><tr><td>&#x02003;Rollins 2007 [<xref ref-type="bibr" rid="CR44">44</xref>]</td><td>South Africa</td><td>Inpatient HIV+ children 6&#x02013;36 mo with persistent diarrhea (4 or more loose or watery stools/day, for 5&#x000a0;days or more)</td><td>Enhanced nutritional support: standard nutritional support + extra protein to provide 150&#x000a0;kcal/kg/day and 4.0&#x02013;5.5&#x000a0;g protein/kg/day (as milk or powdered protein, depending on age), until diarrhea resolved</td><td>Standard nutritional support: maize porridge + milk formula, until diarrhea resolved</td><td>104</td><td>26&#x000a0;weeks</td><td>Mortality, median change in weight-SDs <sup>iv</sup>and WAZ at 26&#x000a0;weeks; proportions underweight (WAZ&#x02009;&#x0003c;&#x02009;&#x02212;&#x02009;2 SDs) and stunted (LAZ&#x02009;&#x0003c;&#x02009;&#x02212;&#x02009; 2 SDs) at 26&#x000a0;weeks (powered for outcome of weight change)</td><td>Very low<sup>&#x003a9;, &#x003a6;, &#x003d1;, &#x003a8;</sup></td></tr><tr><td colspan="9">Lactose Free Diet</td></tr><tr><td>&#x02003;Bhan 1988 [<xref ref-type="bibr" rid="CR16">16</xref>]</td><td>India</td><td>Outpatient children 3&#x02013;24 mo</td><td>Legume and cereal-based formula (lactose-free), until recovery or a minimum of 7&#x000a0;days</td><td>Calorically equivalent milk-based formula, until recovery or a minimum or 7&#x000a0;days</td><td>57</td><td>At least 7&#x000a0;days, or until end of diarrhea</td><td>Weight gain at day 7 and at recovery compared to admission weight (power/sample size calculations not reported)</td><td>Very low<sup>&#x003a9;, &#x003a6;, &#x003d1;, &#x003a8;</sup></td></tr><tr><td>&#x02003;Bhutta 1991 [<xref ref-type="bibr" rid="CR50">50</xref>]</td><td>Pakistan</td><td>Outpatient males 6 mo - 3 yo with persistant diarrhea (increased frequeny and reduced consistency lasting 2&#x000a0;weeks or more)</td><td>Soy milk (lactose-free) for 7&#x000a0;days, followed by khitchri and yogurt for 7&#x000a0;days</td><td>Khitchri and yogurt for 14&#x000a0;days</td><td>73</td><td>14&#x000a0;days</td><td>Weight gain at day 7 and 14 compared to admission weight (power/sample size calculations not reported)</td><td>Very low<sup>&#x003a9;, &#x003a6;, &#x003d1;, &#x003a8;</sup></td></tr><tr><td>&#x02003;Lozano 1994 [<xref ref-type="bibr" rid="CR38">38</xref>]</td><td>Colombia</td><td>Inpatient children 1&#x02013;24 mo with diarrhea (4 or more watery stools in a 24&#x000a0;h period) and dehydration</td><td>Lactose-free feeding formula, 21&#x000a0;days</td><td>Feeding formula with lactose, 21&#x000a0;days</td><td>52</td><td>6&#x000a0;weeks post-discharge</td><td>Weight increment at 6&#x000a0;weeks (powered for outcomes of diarrhea duration)</td><td>Very low<sup>&#x003a9;, &#x003a6;, &#x003d1;, &#x003a8;</sup></td></tr><tr><td>&#x02003;Bhatnagar 1996 [<xref ref-type="bibr" rid="CR17">17</xref>]</td><td>India</td><td>Inpatient \children 3&#x02013;24 mo, with persistent diarrhea (3 or more liquid stools/day for 14&#x000a0;days)</td><td>Puffed rice cereal, sugar, oil, and milk protein, 120&#x000a0;h</td><td>Puffed rice cereal, sugar, oil, and egg white protein (lactose-free), 120&#x000a0;h</td><td>116</td><td>4&#x02013;6&#x000a0;weeks after discharge</td><td>Proportion of patients whose weight on day 7 was lower than at rehydration; probability of continuing diarrhea at each day to day 12 (power/sample size calculations not reported)</td><td>Very low<sup>&#x003a9;, &#x003a6;, &#x003a8;</sup></td></tr><tr><td>&#x02003;de Mattos 2009 [<xref ref-type="bibr" rid="CR37">37</xref>]</td><td>Brazil</td><td>Inpatient male infants 1&#x02013;30 mo with persistent diarrhea (3 or more liquid stools per day for 14&#x000a0;days)</td><td>Amino-acid based diet or soy-based diet, or hydrolyzed protein-based diet<sup>v</sup></td><td>Yogurt-based diet</td><td>154</td><td>7&#x000a0;days post-discharge</td><td>Difference in weight gain and change in WHZ at discharge compared to admission measurements (powered for outcomes of stool output and diarrhea duration)</td><td>Very low<sup>&#x003a9;, &#x003a6;, &#x003d1;, &#x003a8;</sup></td></tr><tr><td colspan="9">Other Dietary Interventions</td></tr><tr><td>&#x02003;Eichenberger 1984 [<xref ref-type="bibr" rid="CR35">35</xref>]</td><td>Brazil</td><td>Inpatient infants 1&#x02013;11 mo with acute to subacute gastroenteritis with diarrhea</td><td>Semi-elemental diet with low osmolarity and high content of hydrolyzed lactalbumin</td><td>Standard hospital diet</td><td>38</td><td>21&#x000a0;days</td><td>Weight at day 21 compared to weight at beginning of therapy (power/sample size calculations not reported)</td><td>Very low <sup>&#x003a9;, &#x003a6;, &#x003d1;, &#x003a8;</sup></td></tr><tr><td>&#x02003;van der Kam 2016 [<xref ref-type="bibr" rid="CR45">45</xref>]</td><td>Uganda</td><td>Non-malnourished, outpatient children 6&#x02013;59 mo with diarrhea (3 or more loose stools [bloody or nonbloody] per 24&#x000a0;h by mothers&#x02019; report), malaria, or lower respiratory tract infections</td><td>Ready-to-use Therapeutic Foods (RUTF), plus instructions to feed the child an extra meal/day for 14 d; or micronutrient powder plus instructions to feed the child an extra meal/day for 14 d</td><td>An instruction to feed the child an extra meal/day for 14 d</td><td>941 with diarrhea only</td><td>6&#x000a0;months</td><td>Incidence of WHZ&#x02009;&#x0003c;&#x02009;&#x02212;&#x02009;2, MUAC &#x0003c;&#x02009;115&#x000a0;mm, or nutritional oedema during follow up (powered for combined outcome of negative nutritional outcome)<sup>vi</sup></td><td>Low <sup>&#x003d1;, &#x003a8;</sup></td></tr><tr><td>&#x02003;van der Kam 2016 [<xref ref-type="bibr" rid="CR46">46</xref>]</td><td>Nigeria</td><td>Non-malnourished or moderately malnourished outpatient children 6&#x02013;59 mo with diarrhea (3 or more loose stools [bloody or nonbloody] per 24&#x000a0;h by mothers&#x02019; report), malaria, or lower respiratory tract infections</td><td>Ready-to-use Therapeutic Foods (RUTF), plus instructions to feed the child an extra meal/day for 14 d; or micronutrient powder plus instructions to feed the child an extra meal/day for 14 d</td><td>An instruction to feed the child an extra meal/day for 14 d</td><td>1171 with diarrhea only</td><td>6&#x000a0;months</td><td><italic>For non-malnourished children at enrollment</italic>: Incidence of WHZ&#x02009;&#x0003c;&#x02009;&#x02212;&#x02009;2, MUAC &#x0003c;&#x02009;115&#x000a0;mm, or nutritional oedema during follow up. <italic>For malnourished children at enrollment</italic>: Incidence of WHZ&#x02009;&#x0003c;&#x02009;&#x02212;&#x02009;3, MUAC &#x0003c;&#x02009;115&#x000a0;mm, nutritional oedema. Or &#x0003e;&#x02009;10% weight loss during follow up. Powered for combined outcome of negative nutritional outcome<sup>vii</sup></td><td>Low <sup>&#x003d1;, &#x003a8;</sup></td></tr><tr><td colspan="9">Oral Rehydration Solution Formulations</td></tr><tr><td>&#x02003;Santosham 1983 [<xref ref-type="bibr" rid="CR39">39</xref>]</td><td>Panama</td><td>Inpatient 3 mo - 2 y/o who were well nourished, with acute diarrhea (more than 3 watery stools per day)</td><td>High potassium and chloride ORS, or standard WHO-ORS</td><td>Standard diet for diarrhea management (aerated beverages, bananas, cereals, and apple sauce)</td><td>93</td><td>14&#x000a0;days</td><td>Weight at day 14, weight gain at day 14 as percent of enrollment weight (power/sample size calculations not reported)</td><td>Very low<sup>&#x003a9;, &#x003a6;, &#x003a8;</sup></td></tr><tr><td>&#x02003;Ribeiro 1991 [<xref ref-type="bibr" rid="CR40">40</xref>]</td><td>Brazil</td><td>Inpatient male infants less than 12 mo, with acute diarrhea and dehydration</td><td>Standard WHO-ORS with 30&#x000a0;mmol/L alanine</td><td>Standard WHO-ORS</td><td>18</td><td>7&#x000a0;days</td><td>Weight gain at day 7 (power/sample size calculations not reported)</td><td>Moderate<sup>&#x003a9;</sup></td></tr><tr><td>&#x02003;Faruque 1997 [<xref ref-type="bibr" rid="CR21">21</xref>]</td><td>Bangladesh</td><td>Inpatient children 3&#x02013;35 mo with acute non-dysenteric diarrhea</td><td>Glucose based ORS</td><td>Rice-powder based ORS</td><td>471</td><td>16&#x000a0;days</td><td>Proportion with diarrhea at day 14, weight gain at day 16 (powered for outcomes of stool output, diarrhea duration and weight gain [70&#x000a0;g])</td><td>Low <sup>&#x003a6;, &#x003a8;</sup></td></tr><tr><td>&#x02003;Alam 2009 [<xref ref-type="bibr" rid="CR55">55</xref>]</td><td>Bangladesh</td><td>Severely malnourished (&#x0003c;&#x02009; 70% NCHS standard), inpatient infants 6&#x02013;60 mo with acute diarrhea and culture-confirmed <italic>V. cholerae</italic></td><td>Glucose-based ORS, or Glucose-based ORS plus amylase resistant starch</td><td>Rice-based ORS</td><td>137</td><td>6&#x000a0;weeks</td><td>Time to attain 80% of median WLZ from enrollment; proportion with diarrhea at or after day 7 (power/sample size calculations not reported)</td><td>Low<sup>&#x003a9;, &#x003a8;</sup></td></tr><tr><td colspan="9">Probiotics</td></tr><tr><td>&#x02003;Boudraa 2001 [<xref ref-type="bibr" rid="CR47">47</xref>]</td><td>Algeria</td><td>Inpatient children 3&#x02013;24 mo with acute watery diarrhea (&#x0003e;&#x02009; 3 loose stools in the previous 24&#x000a0;h)</td><td>Standard formula fermented with <italic>L. bulgaricus</italic> and <italic>S. thermophilus</italic> (lactose and calorically equivalent)</td><td>Standard milk-based formula</td><td>97</td><td>7&#x000a0;days</td><td>Weight gain at day 7 (power/sample size calculations not reported)</td><td>Very low<sup>&#x003a9;, &#x003a6;, &#x003d1;, &#x003a8;</sup></td></tr><tr><td>&#x02003;Villaruel 2007 [<xref ref-type="bibr" rid="CR41">41</xref>]</td><td>Argentina</td><td>Outpatient children 3 mo - 2 yo, with acute diarrhea (3 or more liquid or loose stools in the preceding 24&#x000a0;h)</td><td>WHO-ORS and S. boulardii, 250&#x000a0;mg per day (patients &#x0003c;&#x02009;1 yo) or 500&#x000a0;mg per day (patients 1 yo and older)</td><td>WHO-ORS and placebo</td><td>72</td><td>1&#x000a0;month</td><td>Proportion of patients with diarrhea at or after day 7 (power/sample size calculations not reported)</td><td>Low<sup>&#x003a9;, &#x003d1;</sup></td></tr><tr><td>&#x02003;Misra 2009 [<xref ref-type="bibr" rid="CR19">19</xref>]</td><td>India</td><td>Inpatient infants &#x0003c;&#x02009;36 mo with diarrhea (more than 3 stools per day that take the shape of their container)</td><td>Lactobacillus rhamnosus GG (10^9 live bacteria)</td><td>Placebo</td><td>207</td><td>6&#x000a0;weeks</td><td>Change in WHZ at 6&#x000a0;weeks(powered for outcomes of stool output and diarrhea duration)</td><td>High</td></tr><tr><td>&#x02003;Sindhu 2014 [<xref ref-type="bibr" rid="CR20">20</xref>]</td><td>India</td><td>Children 6&#x000a0;m to 5&#x000a0;years with diarrhea testing positive for either rotavirus or Cryptosporidium infection</td><td>Lactobacillus rhamnuosus GG (10^10 organisms)</td><td>Placebo</td><td>123</td><td>4&#x000a0;weeks</td><td>Proportions stunted (HAZ&#x02009;&#x0003c;&#x02009;&#x02212;&#x02009;2 SD), underweight (WAZ&#x02009;&#x0003c;&#x02009;&#x02212;&#x02009; 2 SD), and wasted (WHZ&#x02009;&#x0003c;&#x02009;&#x02212;&#x02009; 2 SD) at 4&#x000a0;weeks, proportion with diarrhea or severe diarrhea during follow-up (powered for outcome of L:M ratio)</td><td>Moderate<sup>&#x003a9;</sup></td></tr><tr><td>&#x02003;Dinleyici 2014 [<xref ref-type="bibr" rid="CR52">52</xref>]</td><td>Turkey</td><td>Inpatient children 3&#x02013;60 mo with acute watery diarrhea</td><td>WHO-ORS&#x02009;+&#x000a0;<italic>lactobacillus reuteri</italic> 17,938 (10^8 CFU) for 5&#x000a0;days</td><td>WHO-ORS only</td><td>127</td><td>12&#x000a0;days</td><td>Proportion with diarrhea at day 12 (powered for outcome of diarrhea duration)</td><td>Very low<sup>&#x003a9;, &#x003a6;,&#x003a8;</sup></td></tr><tr><td colspan="9">Therapeutic Micronutrients (Vitamin A and Zinc)<sup>viii</sup></td></tr><tr><td>&#x02003;Faruque 1999 [<xref ref-type="bibr" rid="CR34">34</xref>]</td><td>Bangladesh</td><td>Inpatient children 6 mo - 2 yo with acute diarrhea (3 or more liquid stools in the previous 24&#x000a0;h)</td><td>4500 &#x003bc;g vitamin A, 15&#x000a0;day, 14.2&#x000a0;mg Zinc acetate, 15&#x000a0;days, or both<sup>ix</sup></td><td>Placebo</td><td>656</td><td>17&#x000a0;days</td><td>Proportion with diarrhea at day 7 and 16 (powered for outcome of diarrhea duration)</td><td>High</td></tr><tr><td>&#x02003;Khatun 2001 [<xref ref-type="bibr" rid="CR22">22</xref>]</td><td>Bangladesh</td><td>Inpatient children 6 mo - 4 yo with persistent diarrhea (diarrhea for &#x0003e;&#x02009;14&#x000a0;days duration)</td><td>Multivitamin (D, C, B1 B2 B6) syrup and 20&#x000a0;mg elemental zinc (as zinc acetate, 5&#x000a0;ml twice daily for 7&#x000a0;days), multivitamin syrup with Vit A (100,000&#x000a0;IU for children &#x0003c;&#x02009;1 yo, 200,000 for children &#x0003e;&#x02009;1 yo), or both</td><td>Multivitamin (D, C, B1 B2 B6) syrup only</td><td>93</td><td>7&#x000a0;days</td><td>Weight at day 7, weight gain at day 7 compared to day 1, proportions with diarrhea at day 7 (powered for outcome of clinical recovery)</td><td>Moderate<sup>&#x003a9;</sup></td></tr><tr><td colspan="9">Therapeutic Micronutrients (Zinc Alone)</td></tr><tr><td>&#x02003;Sazawal 1995 [<xref ref-type="bibr" rid="CR23">23</xref>]</td><td>India</td><td>Inpatient children 6&#x02013;35 mo, with acute diarrhea (at least 4 unformed stools in the preceding 24&#x000a0;h)</td><td>Multivitamin syrup (A, B2, B6, D3, E) plus zinc gluconate (20&#x000a0;mg of elemental zinc)</td><td>Multivitamin syrup (A, B2, B6, D3, E) only</td><td>937</td><td>At least 120&#x000a0;days</td><td>Proportion of diarrhea episodes that last longer than 7&#x000a0;days, proportion of diarrhea episodes taken to a physician during follow up (power/sample size calculations not reported)</td><td>High</td></tr><tr><td>&#x02003;Roy 1998 [<xref ref-type="bibr" rid="CR24">24</xref>]</td><td>Bangladesh</td><td>Inpatient 3&#x02013;24 mo with persistent diarrhea</td><td>Multivitamin syrup (Vit A, B1, B2, B3, B6, D, Ca) with 20&#x000a0;mg elemental zinc per day for 14&#x000a0;days</td><td>Multivitamin syrup (Vit A, B1, B2, B3, B6, D, Ca) only for 14&#x000a0;days</td><td>141</td><td>15&#x000a0;days</td><td>Mortality, weight gain at discharge compared to admission weight, proportion with diarrhea after day 15 (powered for outcome of diarrhea duration)</td><td>Very low<sup>&#x003a9;, &#x003a6;, &#x003d1;</sup></td></tr><tr><td>&#x02003;Bhutta 1999 [<xref ref-type="bibr" rid="CR49">49</xref>]</td><td>Pakistan</td><td>Inpatient children 6&#x02013;36 mo with persistent diarrhea</td><td>Multivitamin syrup (Vit A, B1, B2, B3, B6, B12, C, D, Ca) with 3&#x000a0;mg elemental zinc per kg per day for 28&#x000a0;days</td><td>Multivitamin syrup (Vit A, B1, B2, B3, B6, B12, C, D, Ca) only for 28&#x000a0;days</td><td>77</td><td>28&#x000a0;days</td><td>Weight gain at day 7 and 14; overall weightincrement at day 14; MUAC at day 7 and 14; overall MUAC increment (powered for outcome of day 14 weight gain)</td><td>Low<sup>&#x003a9;, &#x003d1;</sup></td></tr><tr><td>&#x02003;Roy 1999 [<xref ref-type="bibr" rid="CR25">25</xref>]</td><td>Bangladesh</td><td>Malnourished (&#x0003c;&#x02009;76% of NCHS median), inpatient children 3&#x02013;24&#x000a0;months with acute diarrhea</td><td>Multivitamin syrup (vit A, B1, B2, B6, D, and Ca) with 20&#x000a0;mg elemental zinc per day for 14&#x000a0;days</td><td>Multivitamin syrup (vit A, B1, B2, B6, D, and Ca) only for 14&#x000a0;days</td><td>29</td><td>10&#x000a0;weeks</td><td>Weight gain at each week of for 8&#x000a0;weeks, length gain at each week for 8&#x000a0;weeks (power/sample size calculations not reported)</td><td>Low<sup>&#x003a9;, &#x003d1;</sup></td></tr><tr><td>&#x02003;Baqui 2002 [<xref ref-type="bibr" rid="CR27">27</xref>]</td><td>Bangladesh</td><td>Community-based children 3&#x02013;59 mo with diarrhea of any duration</td><td>ORS with 20&#x000a0;mg zinc per day, 14&#x000a0;days</td><td>ORS only</td><td>8070</td><td>2&#x000a0;years<sup>x</sup></td><td>Incidence of diarrhea, mortality (powered for the outcomes of diarrhea duration, diarrhea incidence, acute lower respiratory infections incidence, admission to hospital for diarrhoea or acute lower respiratory infections, and child mortality)</td><td>Low <sup>&#x003a6;, &#x003a8;</sup></td></tr><tr><td>&#x02003;Walker 2007 [<xref ref-type="bibr" rid="CR53">53</xref>]</td><td>Ethiopia, Pakistan, and India</td><td>Infants 1&#x02013;5 mo with acute diarrhea, identified through home visits by health workers and community based study clinics</td><td>ORS with 10&#x000a0;mg zinc sulfate, daily for 14&#x000a0;days</td><td>ORS with placebo</td><td>1042</td><td>8&#x000a0;weeks</td><td>Weight at week 4 and 8, length at week 4 and 8, proportion of infants with &#x02265;1 episode of any diarrhea, &#x02265; 2 episode of any diarrhea, or &#x02265;1 episode of dysentery (any day with blood in the stool); incidence and prevalence of diarrhea; mortality (powered for anthropometry and morbidity outcomes)</td><td>High</td></tr><tr><td>&#x02003;Roy 2007 [<xref ref-type="bibr" rid="CR28">28</xref>]</td><td>Bangladesh</td><td>Convalescent children 3&#x02013;24 mo, after recovery from persistent diarrhea</td><td>Multivitamin syrup (Unspecified) with 20&#x000a0;mg elemental zinc, 14&#x000a0;days</td><td>Multivitamin syrup (unspecified) only, 14&#x000a0;days</td><td>147</td><td>12&#x000a0;weeks</td><td>Mortality, gain in length and weight at 12&#x000a0;weeks, incidence of subsequent diarrhea episodes (power/sample size calculations not reported)</td><td>Low<sup>&#x003a9;, &#x003a6;, &#x003d1;</sup></td></tr><tr><td>&#x02003;Roy 2008 [<xref ref-type="bibr" rid="CR29">29</xref>]</td><td>Bangladesh</td><td>Moderately malnourished (weight/age 61&#x02013;75% of NCHS median), inpatient children age 12&#x02013;59&#x000a0;m with acute bloody-mucoid diarrhea or febrile diarrhea, and lab-confirmed <italic>Shigella spp</italic></td><td>Multivitamin syrup (A, D, B complex, Ca) with zinc acete (10&#x000a0;mg elemental Zn/5&#x000a0;mL), for 14&#x000a0;days</td><td>Multivitamin syrup (Vit A, D, B complex, Ca) only</td><td>30<sup>xi</sup></td><td>6&#x000a0;months</td><td>Diarrhea incidence and duration of episodes during 6 mo follow up (power/sample size calculations not reported)</td><td>Low<sup>&#x003a9;, &#x003d1;</sup></td></tr><tr><td>&#x02003;Fajolu 2008 [<xref ref-type="bibr" rid="CR48">48</xref>]</td><td>Nigeria</td><td>Outpatient children 6&#x02013;24 mo with acute diarrhea (3 or more loose, liquid or watery stools in a 24&#x000a0;h period)</td><td>20&#x000a0;mg of elemental zinc (zinc sulphate monohydrate) for patients &#x0003e;&#x02009;1 y/o, 10&#x000a0;mg of elemental zinc, 14&#x000a0;days, for patients &#x0003c;&#x02009;1 y/o</td><td>Placebo</td><td>60</td><td>3&#x000a0;months</td><td>Weight gain at 3&#x000a0;months, number and duration of subsequent diarrhea episodes during follow up (power/sample size calculations not reported)</td><td>Moderate<sup>&#x003a9;</sup></td></tr><tr><td>&#x02003;Larson 2010 [<xref ref-type="bibr" rid="CR30">30</xref>]</td><td>Bangladesh</td><td>Community-based children 6&#x02013;23 mo with acute diarrhea and culture-confirmed ETEC</td><td>10&#x000a0;days of zinc (10&#x000a0;mg/d)&#x02009;+&#x02009;additional 3&#x000a0;months of zinc supplementation (10&#x000a0;mg/d)</td><td>10&#x000a0;days of zinc (10&#x000a0;mg/d) only</td><td>333</td><td>9&#x000a0;months</td><td>Incidence rate of diarrhea illness during follow up (powered for the incidence of acute upper respiratory tract infections)</td><td>Moderate<sup>&#x003d1;</sup></td></tr><tr><td>&#x02003;Alam 2011 [<xref ref-type="bibr" rid="CR31">31</xref>]</td><td>Bangladesh</td><td>Community-based children 4&#x02013;59 mo with diarrhea (3 or more loose or liquid stools in the previous 24&#x000a0;h)</td><td>Short course zinc - 20&#x000a0;mg elemental zinc, 5&#x000a0;days</td><td>Standard course zinc - 20&#x000a0;mg elemental zinc, 10&#x000a0;days</td><td>1622</td><td>90&#x000a0;days</td><td>Number of diarrheal episodes and days of diarrhea during follow up; proportion with at least 1 subsequent episode of diarrhea, prolonged diarrhea, or persistent diarrhea during follow up; day of onset of first subsequent diarrhea episode during follow up (powered for the outcome of diarrhea incidence)</td><td>High</td></tr><tr><td>&#x02003;Patel 2013 [<xref ref-type="bibr" rid="CR32">32</xref>]</td><td>India</td><td>Outpatient children 6&#x02013;59 mo with acute diarrhea (&#x0003e;&#x02009;3 unformed stools in the previous 24&#x000a0;h per mother&#x02019;s report)</td><td>Zinc (2&#x000a0;mg/kg/day) or zinc + copper (Zn 2&#x000a0;mg/kg/day + Cu 0.2&#x000a0;mg/kg/day), 14&#x000a0;days</td><td>Placebo</td><td>724</td><td>12&#x000a0;weeks</td><td>Proportion with at least 1 diarrhea episode, 2 diarrhea episodes, or 1 dysentery episode during follow up; number and duration of subsequent diarrhea episodes; change in WAZ, WHZ, and HAZ from enrollment measurements every 2&#x000a0;weeks for 12&#x000a0;weeks (power/sample size calculations not reported)</td><td>High</td></tr><tr><td>&#x02003;Negi 2015 [<xref ref-type="bibr" rid="CR33">33</xref>]</td><td>India</td><td>Children 5&#x02013;12&#x000a0;yrs. presenting to pediatric emergency units with acute watery diarrhea (3 or more episodes of loose stools over 24&#x000a0;h of &#x0003c;&#x02009;72&#x000a0;h duration), with some or severe dehydration, and having had no treatment</td><td>Zinc (20&#x000a0;mg/day) for 14&#x000a0;days</td><td>Placebo</td><td>134</td><td>3&#x000a0;months</td><td>Risk of having at least 1 episode of diarrhea during follow up (power/sample size calculations not reported)</td><td>Low<sup>&#x003a9;, &#x003d1;</sup></td></tr></tbody></table><table-wrap-foot><p><sup>i</sup>Outcome listed are only the outcomes of interest for the present systematic review</p><p><sup>ii</sup>Duration of diets was variable. Diets were started at low concentrations and were advanced every 48 hours if no sign of intolerance. If there were signs of intolerance, diets were maintained or decreased as necessary. When full concentrations were reached, the diet was given for an additional 7 days.</p><p><sup>iii</sup>Defined as when diarrhea had ceased and patient had consistent weight gain for at least 48 hours</p><p><sup>iv</sup>Defined as age- and sex-specific weight standard deviation scores, from the National Center for Health Statistics median value</p><p><sup>v</sup>All diets were equivalent in calorie and protein composition</p><p><sup>vi</sup>Study included children with multiple admission (not just diarrhea) therefore only included data for children who had diarrhea at time of treatment. Power was determined for all children (not stratified by diagnosis)</p><p><sup>vii</sup>Study included children with multiple admission (not just diarrhea) therefore only included data for children who had diarrhea at time of treatment. Power was determined for all children (not stratified by diagnosis)</p><p><sup>viii</sup>Studies in this intervention category are randomized controlled trials with a factorial design, evaluating both Vitamin A and Zinc</p><p><sup>ix</sup>Investigators included 2 strata of study subjects: A &#x0201c;standard dose stratum&#x0201d; with the dosages given, and a &#x0201c;High dose stratum&#x0201d; with 40 mg zinc acetate daily, 15 days (Vit A dosage was unchanged)</p><p><sup>x</sup>Diarrhea morbidity data were collected from &#x0201c;samples of time periods&#x0201d; throughout the 2 year follow up period. Mortality rates were calculated using 11,881 child-years of person-time, and incidence rates were calculated using 41,788 child-weeks of person-time</p><p><sup>xi</sup>Thirty completed 6 month follow up; 50 completed 7-day clinical study</p><p><sup>&#x003a9;</sup>Sparse data (sample size is &#x0003c;200 participants total)</p><p><sup>&#x003a6;</sup>Blinding and allocation process (not double-blind)</p><p><sup>&#x003d1;</sup>Follow up and withdrawals (&#x0003e;5% of sample size)</p><p><sup>&#x003a8;</sup>Lack of placebo</p></table-wrap-foot></table-wrap></p><p id="Par30">Of the 46 clinical trials evaluated using the modified GRADE system, 6 (13.0%) scored high, 8 (17.4%) scored moderate, 11 (23.9%) scored low, and 21 (45.7%) scored very low (Table <xref rid="Tab1" ref-type="table">1</xref>). The most common deduction was for sparse data (35 [76.1%]), followed by deductions related to follow-up and withdrawals (24 [52.2%]), or blinding/allocation process (21 [45.7%]).</p><sec id="Sec4"><title>Mortality</title><p id="Par31">Seven studies (15.2%) presented data on post-acute mortality, with follow-up ranging from 8-days to 2&#x000a0;years. Four were trials of therapeutic zinc interventions, [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR53">53</xref>], 2 antimicrobial treatments [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR42">42</xref>], and 1 of a high protein diet [<xref ref-type="bibr" rid="CR44">44</xref>]. Two of the zinc trials were large studies (8070 and 1042 subjects, respectively) [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR53">53</xref>] but the remaining 5 included less than 150 participants (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>, Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). None of the 7 trials were adequately powered for a mortality endpoint. Only 1 trial, a cluster randomized trial of zinc, found a lower non-injury mortality rate in children living in communities randomized to ORS and zinc compared to those using ORS alone (relative risk [RR]&#x02009;=&#x02009;0.49 [95% confidence interval {95% CI}: 0.25, 0.94]) [<xref ref-type="bibr" rid="CR27">27</xref>]. The remaining 6 studies reported non-significant risk differences ranging in magnitude from 70 more to 105 less deaths per 1000 children [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR44">44</xref>] and relative risks ranging from 0.18 to 1.34 [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR44">44</xref>].<fig id="Fig2"><label>Fig. 2</label><caption><p>Effect of diarrhea management interventions on mortality (relative risk, risk difference, and associated 95% confidence interval)</p></caption><graphic xlink:href="12889_2018_5092_Fig2_HTML" id="MO2"/></fig><table-wrap id="Tab2"><label>Table 2</label><caption><p>Intervention effects on post-acute (&#x02265;7&#x000a0;days after enrollment) mortality, length, weight, and/or diarrhea presence</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Reference</th><th>Intervention</th><th>Comparator</th><th colspan="3">Relevant Outcomes and Results</th></tr></thead><tbody><tr><td colspan="6">Antimicrobial Interventions</td></tr><tr><td rowspan="2">&#x02003;Gilman 1980 [<xref ref-type="bibr" rid="CR8">8</xref>]</td><td rowspan="2">Low dose ampicillin (50&#x000a0;mg/kg/day)</td><td rowspan="2">Standard dose ampicillin (150&#x000a0;mg/kg/day)</td><td rowspan="2">Mortality</td><td>Risk Difference (95% CI)</td><td>&#x02212;0.11 (&#x02212;&#x02009;0.24, 0.03)<sup>i</sup></td></tr><tr><td>Relative Risk (95% CI)</td><td>Undefined</td></tr><tr><td rowspan="2">&#x02003;Amadi 2002 [<xref ref-type="bibr" rid="CR42">42</xref>]</td><td rowspan="2">5&#x000a0;mL of 20&#x000a0;g/L nitazoxanide, twice daily for 3&#x000a0;days</td><td rowspan="2">Placebo</td><td rowspan="2">Mortality</td><td>Risk Difference (95% CI)</td><td>&#x02212;0.07 (&#x02212;&#x02009;0.21, 0.06)</td></tr><tr><td>Relative Risk (95% CI)</td><td>0.58 (0.21, 1.63)</td></tr><tr><td colspan="6">Dietary Supplements</td></tr><tr><td>&#x02003;Alam 2000 [<xref ref-type="bibr" rid="CR26">26</xref>]</td><td>ORS with dietary fiber (Benefiber&#x000ae;)</td><td>WHO- ORS only</td><td>Difference in weight gain at day 7, g (95% CI)</td><td colspan="2">52 (&#x02212;18.73, 122.73)</td></tr><tr><td>&#x02003;Rabbani 2001 [<xref ref-type="bibr" rid="CR15">15</xref>]</td><td>Rice-based diet with dietary fiber (green banana or pectin supplement), 7&#x000a0;days</td><td>Rice-based diet only</td><td>Proportions recovered from diarrhea (formed stool) at each day to day 10</td><td colspan="2">Higher in banana and pectin groups than in control group<sup>ii</sup></td></tr><tr><td rowspan="3">&#x02003;Yalcin 2004 [<xref ref-type="bibr" rid="CR51">51</xref>]</td><td rowspan="3">Glutamine supplement, 0.3&#x000a0;g/kg/day, for 7&#x000a0;days</td><td rowspan="3">Placebo</td><td>Difference in weight gain at day 30, g (95% CI)<sup>iii</sup></td><td colspan="2">130 (12.67, 247.33)</td></tr><tr><td>Difference in weight gain at day 60, g (95% CI)</td><td colspan="2">45 (&#x02212;80.80, 170.80)</td></tr><tr><td>Difference in weight gain at day 90, g (95% CI)</td><td colspan="2">107 (&#x02212;57.30, 271.30)</td></tr><tr><td colspan="6">High Protein Diets</td></tr><tr><td rowspan="2">&#x02003;Datta 1990 [<xref ref-type="bibr" rid="CR9">9</xref>]</td><td rowspan="2">High protein diet, length unspecified</td><td rowspan="2">Standard hospital diet</td><td>Difference in weight at day 15, kg (95% CI)</td><td colspan="2">0.30 (&#x02212;0.18, 0.78)</td></tr><tr><td>Difference in MUAC at day 15, cm (95% CI)</td><td colspan="2">0.00 (&#x02212;0.37, 0.37)</td></tr><tr><td rowspan="6">&#x02003;Kabir 1992 [<xref ref-type="bibr" rid="CR10">10</xref>]</td><td rowspan="6">High protein diet (15% of total energy from protein), 21&#x000a0;days</td><td rowspan="6">Standard diet (7.5% of total energy from protein), 21&#x000a0;days</td><td>Difference in change in weight at day 21 from admission, kg (95% CI)</td><td colspan="2">0.47 (0.12, 0.82)</td></tr><tr><td>Difference in change in height at day 21, from admission, cm (95% CI)</td><td colspan="2">0.09 (&#x02212;0.57, 0.75)</td></tr><tr><td>Difference in change in WAZ at day 21 from admission (95% CI)</td><td colspan="2">0.30 (0.03, 0.57)</td></tr><tr><td>Difference in change in WHZ at day 21 from admission (95% CI)</td><td colspan="2">0.40 (0.05, 0.75)</td></tr><tr><td>Difference in change in MUAC at day 21 from admission, cm (95% CI)</td><td colspan="2">0.44 (0.08, 0.80)</td></tr><tr><td>Difference in change in triceps skinfold thickness at day 21 from admission, cm (95% CI)</td><td colspan="2">0.32 (&#x02212;0.29, 0.93)</td></tr><tr><td rowspan="3">&#x02003;Kabir 1993 [<xref ref-type="bibr" rid="CR11">11</xref>]</td><td rowspan="3">High protein diet, 21&#x000a0;days</td><td rowspan="3">Standard protein diet, 21&#x000a0;days</td><td>Difference in change in WAZ at day 21, from admission (95% CI)</td><td colspan="2">0.23 (0.07, 0.39)</td></tr><tr><td>Difference in change in WHZ at day 21, from admission (95% CI)</td><td colspan="2">0.25 (0.05, 0.45)</td></tr><tr><td>Difference in change in HAZ at day 21, from admission (95% CI)</td><td colspan="2">0.90 (0.05, 0.13)</td></tr><tr><td rowspan="4">&#x02003;Mazumder 1997 [<xref ref-type="bibr" rid="CR12">12</xref>]</td><td rowspan="4">High calorie &#x00026; high protein milk-cereal diet, 4960&#x000a0;kJ/l (10&#x000a0;days)</td><td rowspan="4">Standard diet, 2480&#x000a0;kJ/l (10&#x000a0;days)</td><td rowspan="2">Difference in percent change in WAZ at day 10 and 40, fromadmission (95% CI)</td><td colspan="2">Day 10: 3.50 (1.86, 5.14)</td></tr><tr><td colspan="2">Day 40: 3.11 (0.92, 5.30)</td></tr><tr><td rowspan="2">Difference in percent change in WHZ at day 10 and 40, from admission (95% CI)</td><td colspan="2">Day 10: 3.76 (1.92, 3.60)</td></tr><tr><td colspan="2">Day 40: 3.34 (0.76, 5.90)</td></tr><tr><td rowspan="6">&#x02003;Nurko 1997 [<xref ref-type="bibr" rid="CR36">36</xref>]</td><td rowspan="6">High protein chicken-based diet or high protein soy-based diet (Nursoy formula)<sup>iv</sup></td><td rowspan="6">Calorically equivalent standard &#x0201c;elemental diet&#x0201d; (Vivonex)</td><td rowspan="2">Difference in weight at end of protocol, g<sup>v</sup> (95% CI)</td><td>Comparing soy group to control</td><td>&#x02212;&#x02009;204 (&#x02212;&#x02009;1178.40, 770.40)</td></tr><tr><td>Comparing chicken group to control</td><td>&#x02212;445 (&#x02212;&#x02009;1522.70, 632.70)</td></tr><tr><td rowspan="2">Difference in weight at discharge from enrollment, g (95% CI)</td><td>Comparing soy group to control</td><td>&#x02212;92 (&#x02212;&#x02009;1189.60, 1005.60)</td></tr><tr><td>Comparing chicken group to control</td><td>&#x02212;&#x02009;428 (&#x02212;&#x02009;1539.80, 683.80)</td></tr><tr><td rowspan="2">Proportion with nutritional recovery<sup>vi</sup>(RR [95%])</td><td>Comparing soy group to control</td><td>1.13 (0.79, 1.61)</td></tr><tr><td>Comparing chicken group to control</td><td>1.20 (0.86, 1.7)</td></tr><tr><td rowspan="5">&#x02003;Kabir 1998 [<xref ref-type="bibr" rid="CR13">13</xref>]</td><td rowspan="5">High protein diet (15% of total energy from protein), 21&#x000a0;days</td><td rowspan="5">Standard protein diet (7.5% of total energy from protein), 21&#x000a0;days</td><td>Difference in change in weight at 6 mo, from post-intervention weight, kg (95% CI)</td><td colspan="2">0.10 (&#x02212;0.24, 0.44)</td></tr><tr><td>Difference in change in height at 6 mo, from post-intervention height, cm (95% CI)</td><td colspan="2">1.10 (0.56, 1.64)</td></tr><tr><td>Difference in change in WAZ at 6 mo, from post-intervention WAZ (95% CI)</td><td colspan="2">0.07 (&#x02212;0.17, 0.31)</td></tr><tr><td>Difference in change in WHZ at 6 mo, from post-intervention WHZ (95% CI)</td><td colspan="2">&#x02212;0.09 (&#x02212;&#x02009;0.35, 0.17)</td></tr><tr><td>Difference in change in HAZ at 6 mo, from post-intervention HAZ (95% CI)</td><td colspan="2">0.28 (0.12, 0.44)</td></tr><tr><td>&#x02003;Mazumder 2000 [<xref ref-type="bibr" rid="CR14">14</xref>]</td><td>High calorie &#x00026; protein milk-cereal formula (4960&#x000a0;kJ/l), 10&#x000a0;days</td><td>Control milk-cereal formula (2480&#x000a0;kJ/l), 10&#x000a0;days</td><td>Difference in percent change in WAZ at day 10, from admission WAZ (95% CI)</td><td colspan="2">3.50 (2.08, 4.91)</td></tr><tr><td rowspan="5">&#x02003;Valentiner-Branth 2001 [<xref ref-type="bibr" rid="CR43">43</xref>]</td><td rowspan="5">Counseling on the importance of breastfeeding and of a nutritious diet, and a high protein millet gruel with a multivitamin tablet (including zinc), until the end of a 7&#x000a0;day period without diarrhea</td><td rowspan="5">Counseling on the importance of breastfeeding and of a nutritious diet</td><td rowspan="2">Difference in weight gain at end of intervention and day 90, g/wk.<sup>vii</sup>(95% CI)</td><td>Day 90</td><td>61.50 (49.20, 73.80)</td></tr><tr><td>End of intervention</td><td>12.50 (7.70, 17.30)</td></tr><tr><td rowspan="2">Difference in change in knee heel length at end of intervention and day 90, mm/y (95% CI)</td><td>Day 90</td><td>2.70 (&#x02212;4.60, 10.00)</td></tr><tr><td>End of intervention</td><td>7.50 (4.80, 10.20)</td></tr><tr><td>Difference in change in height between groups at day 90, (cm/y)<sup>2</sup> (95% CI)<sup>viii</sup></td><td colspan="2">0.65 (0.11, 1.19)</td></tr><tr><td rowspan="6">&#x02003;Rollins 2007 [<xref ref-type="bibr" rid="CR44">44</xref>]</td><td rowspan="6">Standard nutritional support + extra protein to provide 150&#x000a0;kcal/kg/day and 4.0&#x02013;5.5&#x000a0;g protein/kg/day</td><td rowspan="6">Standard nutritional support: maize porridge + milk formula</td><td rowspan="2">Mortality at 26&#x000a0;weeks</td><td>Relative risk</td><td>1.34 (95% CI: 0.79, 2.27)</td></tr><tr><td>Risk difference</td><td>7.4% (&#x02212;4.7%,20.5%)</td></tr><tr><td>Median change in weight- SDs <sup>ix</sup>at 26&#x000a0;weeks</td><td colspan="2">Greater gain in intervention group (<italic>p</italic>&#x000a0;&#x0003c;&#x02009;0.001)</td></tr><tr><td>Median change in WAZ at 26&#x000a0;weeks</td><td colspan="2">Greater gain in intervention group (<italic>p</italic>&#x000a0;&#x0003c;&#x02009;0.05)</td></tr><tr><td>Proportion underweight (WAZ&#x02009;&#x0003c;&#x02009;&#x02212;2 SDs) at 26&#x000a0;weeks (Prevalence Ratio [95% CI])</td><td colspan="2">0.48 (0.30, 0.77)</td></tr><tr><td>Proportion stunted (LAZ&#x02009;&#x0003c;&#x02009;&#x02212; 2 SDs) at 26&#x000a0;weeks (Prevalence Ratio[95% CI])</td><td colspan="2">0.87 (0.67, 1.13)</td></tr><tr><td colspan="6">Lactose Free Diets</td></tr><tr><td rowspan="2">&#x02003;Bhan 1988 [<xref ref-type="bibr" rid="CR16">16</xref>]</td><td rowspan="2">Legume and cereal-based formula (lactose-free), until recovery or 7&#x000a0;days min</td><td rowspan="2">Calorically equivalent milk-based formula, until recovery or 7&#x000a0;days min</td><td>Difference in weight gain at day 7, g/kg admission weight/24&#x000a0;h (95% CI)</td><td colspan="2">&#x02212;3.20 (&#x02212;6.86, 0.46)</td></tr><tr><td>Difference in weight gain at recovery, g/kg admission weight/24&#x000a0;h (95% CI)</td><td colspan="2">&#x02212;3.80 (&#x02212;7.15, &#x02212;0.44)</td></tr><tr><td rowspan="2">&#x02003;Bhutta 1991 [<xref ref-type="bibr" rid="CR50">50</xref>]</td><td rowspan="2">Soy milk (lactose-free) for 7&#x000a0;days, followed by khitchri and yogurt for 7&#x000a0;days</td><td rowspan="2">Khitchri and yogurt for 14&#x000a0;days</td><td rowspan="2">Difference in weight gain at day 7 and 14, g/wk. (95% CI)</td><td colspan="2">Day 7: &#x02212;400 (&#x02212;&#x02009;559.40, &#x02212;&#x02009;240.60)</td></tr><tr><td colspan="2">Day 14: 385.7 (209.60, 561.80)</td></tr><tr><td>&#x02003;Lozano 1994 [<xref ref-type="bibr" rid="CR38">38</xref>]</td><td>Corn-based (lactose-free) formula, 21&#x000a0;days</td><td>Milk-based formula, 21&#x000a0;days</td><td>Difference in weight increment at 6&#x000a0;weeks, kg (95% CI)</td><td colspan="2">&#x02212;0.02 (&#x02212;&#x02009;0.30, 0.26)</td></tr><tr><td rowspan="2">&#x02003;Bhatnagar 1996 [<xref ref-type="bibr" rid="CR17">17</xref>]</td><td rowspan="2">Rice-based formula with egg white protein (lactose-free), until discharge</td><td rowspan="2">Rice-based formula with milk protein, until discharge</td><td>Proportion of patients whose weight on day 7 was lower than at rehydration (Prevalence Ratio [95% CI])</td><td colspan="2">0.97 (0.06, 15.19)</td></tr><tr><td>Probability of continuing diarrhea at each day to day 12</td><td colspan="2">No significant difference (p&#x02009;=&#x02009;0.76)<sup>x</sup></td></tr><tr><td rowspan="2">&#x02003;de Mattos 2009 [<xref ref-type="bibr" rid="CR37">37</xref>]</td><td rowspan="2">Amino-acid based diet, isolated soy-based, or hyrolyzed casein-based diet; until discharge</td><td rowspan="2">Yogurt-based diet<sup>xi</sup> until discharge</td><td>Difference in weight gain at discharge among groups at discharge</td><td colspan="2">No difference among groups<sup>xii</sup></td></tr><tr><td>Change in WHZ at discharge</td><td colspan="2">Similar improvement in all groups<sup>xiii</sup></td></tr><tr><td colspan="6">Other Dietary Interventions</td></tr><tr><td>&#x02003;Eichenberger 1984 [<xref ref-type="bibr" rid="CR35">35</xref>]</td><td>Semi-elemental diet with low osmolarity and high hydrolyzed lactalbumin, at least 21&#x000a0;days</td><td>Standard hospital diet</td><td>Weight at day 21 compared to weight at beginning of therapy</td><td colspan="2">Better in intervention group<sup>xiv</sup></td></tr><tr><td rowspan="3">&#x02003;van der Kam 2016 (Uganda) [<xref ref-type="bibr" rid="CR45">45</xref>]</td><td rowspan="3">RUTF, plus instructions to feed the child an extra meal/day for 14 d; or micronutrient powder plus instructions to feed the child an extra meal/day for 14 d</td><td rowspan="3">An instruction to feed the child an extra meal/day for 14 d</td><td rowspan="3">Relative Risk of first event of malnutrition (95% CI)</td><td>RUTF vs micronutrient group</td><td>0.68 (0.37, 1.22)</td></tr><tr><td>RUTF vs control group</td><td>0.62 (0.35, 1.10)</td></tr><tr><td>Micronutrient group vs control</td><td>0.92 (0.54, 1.54)</td></tr><tr><td rowspan="3">&#x02003;van der Kam 2016 (Nigeria) [<xref ref-type="bibr" rid="CR46">46</xref>]</td><td rowspan="3">RUTF, plus instructions to feed the child an extra meal/day for 14 d; or micronutrient powder plus instructions to feed the child an extra meal/day for 14 d</td><td rowspan="3">An instruction to feed the child an extra meal/day for 14 d</td><td rowspan="3">Relative Risk of first event of malnutrition (95% CI)</td><td>RUTF vs micronutrient group</td><td>1.12 (0.84, 1.50)</td></tr><tr><td>RUTF vs control group</td><td>0.91 (0.69, 1.20)</td></tr><tr><td>Micronutrient group vs control</td><td>0.81 (0.61,1.09<sup>xv</sup>)</td></tr><tr><td colspan="6">ORS Formulations</td></tr><tr><td rowspan="4">&#x02003;Santosham 1983 [<xref ref-type="bibr" rid="CR39">39</xref>]</td><td rowspan="4">High potassium/ high chloride ORS, or standard WHO-ORS, with regular diet</td><td rowspan="4">Standard diet for diarrhea management</td><td rowspan="2">Difference in weight at day 14, kg (95% CI)</td><td>Comparing high potassium/chloride to control</td><td>&#x02212;0.3 (&#x02212;1.45, 0.85)</td></tr><tr><td>Comparing standard ORS to control</td><td>&#x02212;0.50 (&#x02212;&#x02009;1.86, 0.76)</td></tr><tr><td rowspan="2">Difference in percent weight gain at day 14 (95% CI)</td><td>Comparing high potassium/chloride to control</td><td>2.00 (1.57, 2.42)</td></tr><tr><td>Comparing standard ORS to control</td><td>2.30 (1.82, 2.77)</td></tr><tr><td>&#x02003;Ribeiro 1991 [<xref ref-type="bibr" rid="CR40">40</xref>]</td><td>Alanine-based ORS</td><td>Standard WHO-ORS</td><td>Difference in weight gain at day 7, g (95% CI)</td><td colspan="2">18 (&#x02212;94.37, 130.38)</td></tr><tr><td rowspan="2">&#x02003;Faruque 1997 [<xref ref-type="bibr" rid="CR21">21</xref>]</td><td rowspan="2">Glucose-based ORS</td><td rowspan="2">Rice powder-based ORS, equivalent in electrolyte content</td><td>Proportion with diarrhea at day 14 (RR [95% CI])</td><td colspan="2">0.80 (0.21, 2.95)</td></tr><tr><td>Difference in weight gain at day 16, g</td><td colspan="2">Similar between groups<sup>xvi</sup></td></tr><tr><td rowspan="4">&#x02003;Alam 2009 [<xref ref-type="bibr" rid="CR55">55</xref>]</td><td rowspan="4">Glucose-based ORS, or glucose-based ORS with amylase-resistant starch (ARS)</td><td rowspan="4">Rice-based ORS</td><td rowspan="2">Difference in time to attain 80% of median WLZ, days (95% CI)</td><td>Difference between glucose and rice ORS</td><td>&#x02212;&#x02009;0.06 (&#x02212;&#x02009;1.19, 1.07)</td></tr><tr><td>Difference between glucose with amylase resistant starch and rice ORS</td><td>&#x02212;&#x02009;0.08 (&#x02212;&#x02009;1.20, 1.04)</td></tr><tr><td rowspan="2">Proportion with diarrhea at or after day 7 (RR [95% CI])</td><td>Risk in glucose ORS group compared to rice ORS group (RR, [95% CI])</td><td>1.00 (0.15, 6.86)</td></tr><tr><td>Risk in glucose with ARS group compared to rice ORS groups (RR, [95% CI])</td><td>0.49 (0.05, 5.27)</td></tr><tr><td colspan="6">Probiotics</td></tr><tr><td rowspan="2">&#x02003;Boudraa 2001 [<xref ref-type="bibr" rid="CR47">47</xref>]</td><td rowspan="2">Milk-based formula fermented with <italic>L. bulgaricu</italic>s <italic>S. andthermophilus</italic></td><td rowspan="2">Milk-based formula only</td><td>Difference in weight gain at day 7, g (95% CI)</td><td colspan="2">43 (&#x02212;&#x02009;109.18, 195.18)</td></tr><tr><td>Difference in weight gain at day 7, g/kg (95% CI)</td><td colspan="2">4.4 (&#x02212;5.50, 14.30)</td></tr><tr><td rowspan="2">&#x02003;Villarruel 2007 [<xref ref-type="bibr" rid="CR41">41</xref>]</td><td rowspan="2"><italic>S. boulardii</italic> capsules</td><td rowspan="2">Placebo</td><td>Proportion with diarrhea on day 7 (Prevalence Ratio [95% CI])</td><td colspan="2">0.39 (0.20, 0.74)</td></tr><tr><td>Proportion with diarrhea after day 7 (Prevalence Ratio [95% CI])</td><td colspan="2">0.25 (0.07, 0.82)</td></tr><tr><td>&#x02003;Misra 2009 [<xref ref-type="bibr" rid="CR19">19</xref>]</td><td><italic>L. rhamnosus</italic> GG 10<sup>9</sup> CFU</td><td>Placebo</td><td>Difference in change in WHZ at 6&#x000a0;weeks</td><td colspan="2">No difference between groups (<italic>p</italic>&#x000a0;=&#x02009;0.06)</td></tr><tr><td rowspan="6">&#x02003;Sindhu 2014 [<xref ref-type="bibr" rid="CR20">20</xref>]</td><td rowspan="6"><italic>L. rhamnosus</italic> GG 10<sup>10</sup> CFU</td><td rowspan="6">Placebo</td><td>Proportion with diarrhea at 4&#x000a0;weeks follow up (Prevalence Ratio [95% CI])</td><td colspan="2">0.65 (0.40, 1.07)</td></tr><tr><td>Proportion with severe diarrhea during follow-up (Prevalence Ratio [95% CI])</td><td colspan="2">1.15 (0.65, 2.05)</td></tr><tr><td>Proportion with diarrhea requiring hospitalization during follow-up (Prevalence Ratio [95% CI])</td><td colspan="2">1.03 (0.54, 1.98)</td></tr><tr><td>Proportion stunted (HAZ&#x02009;&#x0003c;&#x02009;&#x02212;2 SD) at week 4 (Prevalence Ratio [95% CI])</td><td colspan="2">1.77 (1.00, 3.13)</td></tr><tr><td>Proportion wasted (WHZ&#x02009;&#x0003c;&#x02009;&#x02212;&#x02009;2 SD) at week 4 (Prevalence Ratio [95% CI])</td><td colspan="2">0.53 (0.16, 1.71)</td></tr><tr><td>Proportion underweight (WAZ&#x02009;&#x0003c;&#x02009;&#x02212;&#x02009;2 SD) at week 4 (Prevalence Ratio [95% CI])</td><td colspan="2">1.66 (0.83, 3.30)</td></tr><tr><td>&#x02003;Dinleyici 2014 [<xref ref-type="bibr" rid="CR52">52</xref>]</td><td>ORS with <italic>L. reuteri</italic> 17,938 10<sup>8</sup> CFU</td><td>ORS only</td><td>Proportion with diarrhea at day 12 (Prevalence Difference [95% CI])<sup>xvii</sup></td><td colspan="2">0.17 (0.08, 0.26)</td></tr><tr><td colspan="6">Therapeutic Micronutrients (Vitamin A and Zinc)</td></tr><tr><td rowspan="4">&#x02003;Faruque 1999 [<xref ref-type="bibr" rid="CR34">34</xref>]</td><td rowspan="4">Vitamin A (4500 &#x003bc;g retinol equivalent daily for 15&#x000a0;days), zinc acetate (14.2&#x000a0;mg daily for 15&#x000a0;days),<sup>xviii</sup>or both<sup>xix</sup></td><td rowspan="4">Placebo</td><td rowspan="2">Proportion with diarrhea on day 7 (Prevalence Ratio [95% CI])</td><td>Zinc-supplemented vs. non-supplemented</td><td>0.64 (0.43, 0.96)</td></tr><tr><td>Vitamin A &#x02013;supplemented vs. non-supplemented</td><td>0.78 (0.52, 1.49)</td></tr><tr><td rowspan="2">Proportion with diarrhea on day 16 (Prevalence Ratio [95% CI])</td><td>Zinc-supplemented vs. non-supplemented</td><td>0.67 (0.24, 1.85)</td></tr><tr><td>Vitamin A &#x02013;supplemented group vs. non-supplemented</td><td>0.67 (0.24, 1.85)</td></tr><tr><td rowspan="6">&#x02003;Khatun 2001 [<xref ref-type="bibr" rid="CR22">22</xref>]</td><td rowspan="6">Multivitamin syrup with 20&#x000a0;mg elemental zinc (twice daily for 7&#x000a0;days), or multivitamin syrup with Vitamin A<sup>xx</sup> or both</td><td rowspan="6">Multivitamin syrup only</td><td rowspan="3">Difference in change in weight at day 7 compared to day 1, g<sup>xxi</sup></td><td>Zinc group vs control</td><td>0.11&#x000a0;kg (<italic>p</italic>&#x000a0;=&#x02009;0.045)</td></tr><tr><td>Vitamin A group vs control</td><td>0.07&#x000a0;kg (<italic>p</italic>&#x000a0;=&#x02009;0.21)</td></tr><tr><td>Zinc+Vitamin A vs. control</td><td>0.06&#x000a0;kg (<italic>p</italic>&#x000a0;=&#x02009;0.074)</td></tr><tr><td rowspan="3">Proportion with diarrhea at day 7, (Prevalence Ratio [95% CI])</td><td>Zinc group vs. control</td><td>0.23 (0.08, 0.71)</td></tr><tr><td>Vitamin A group vs. control</td><td>0.92 (0.54, 1.59)</td></tr><tr><td>Zinc+Vitamin A vs. control</td><td>0.62 (0.31, 1.21)</td></tr><tr><td colspan="6">Therapeutic Micronutrients (Zinc alone)</td></tr><tr><td rowspan="2">&#x02003;Sazawal 1995 [<xref ref-type="bibr" rid="CR23">23</xref>]</td><td rowspan="2">Multivitamin syrup with 20&#x000a0;mg elemental zinc<sup>xxii</sup></td><td rowspan="2">Multivitamin syrup only</td><td>Proportion of episodes lasting longer than 7&#x000a0;days (Prevalence Ratio [95% CI])</td><td colspan="2">0.87 (0.65, 1.16)</td></tr><tr><td>Proportion of diarrhea episodes taken to a physician during follow up (Prevalence Ratio [95% CI])</td><td colspan="2">0.78 (0.57, 1.07)</td></tr><tr><td rowspan="4">&#x02003;Roy 1998 [<xref ref-type="bibr" rid="CR24">24</xref>]</td><td rowspan="4">Multivitamin syrup with 20&#x000a0;mg elemental zinc, 14&#x000a0;days</td><td rowspan="4">Multivitamin syrup only</td><td rowspan="2">Mortality</td><td>Relative Risk (95% CI)</td><td>0.18 (0.02, 1.49)</td></tr><tr><td>Risk Difference (95% CI)</td><td>&#x02212;0.05 (&#x02212;&#x02009;0.11, 0.01)</td></tr><tr><td>Change in weight at discharge, g<sup>xxiii</sup></td><td colspan="2">Mean body weight in intervention group was maintained while body weight decreased in control group</td></tr><tr><td>Proportion with diarrhea after day 15 (RR [95% CI])<sup>xxiv</sup></td><td colspan="2">0.99 (0.53, 1.88)</td></tr><tr><td rowspan="6">&#x02003;Bhutta 1999 [<xref ref-type="bibr" rid="CR49">49</xref>]</td><td rowspan="6">Multivitamin with 3&#x000a0;mg of elemental zinc per kg of body weight, 28&#x000a0;days</td><td rowspan="6">Multivitamin only</td><td rowspan="2">Difference in weight at day 7 and 14, kg<sup>xxv</sup> (95% CI)</td><td colspan="2">Day 7: &#x02212;0.57 (&#x02212;1.14, &#x02212;&#x02009;0.002)</td></tr><tr><td colspan="2">Day 14: &#x02212;0.46 (&#x02212;&#x02009;1.06, 0.14)</td></tr><tr><td>Difference in overall weight increment at day 14, g/kg/day</td><td colspan="2">1.60 (&#x02212;&#x02009;1.48, 4.68)</td></tr><tr><td rowspan="2">Difference in MUAC at day 7 and 14, cm (95% CI)</td><td colspan="2">Day 7: &#x02212;0.30 (&#x02212;&#x02009;0.98, 0.38)</td></tr><tr><td colspan="2">Day 14: &#x02212;0.40 (&#x02212;1.08, 0.28)</td></tr><tr><td>Difference in overall MUAC increment, cm (95% CI)</td><td colspan="2">0.00 (&#x02212;0.13, 0.13)</td></tr><tr><td rowspan="9">&#x02003;Roy 1999 [<xref ref-type="bibr" rid="CR25">25</xref>]</td><td rowspan="9">Multivitamin with 20&#x000a0;mg of elemental zinc, 14&#x000a0;days</td><td rowspan="9">Multivitamin only</td><td rowspan="8">Difference in weight gain at each week of 8&#x000a0;week follow up, g (95% CI)</td><td colspan="2">Week 1: 30 (&#x02212;204.70, 264.73)</td></tr><tr><td colspan="2">Week 2: &#x02212;4 (&#x02212;&#x02009;202.60, 194.60)</td></tr><tr><td colspan="2">Week 3: &#x02212;45 (&#x02212;303.70, 213.70)</td></tr><tr><td colspan="2">Week 4: &#x02212;60 (&#x02212;&#x02009;347.70, 227.70)</td></tr><tr><td colspan="2">Week 5: &#x02212;79 (&#x02212;361.40, 203.40)</td></tr><tr><td colspan="2">Week 6: &#x02212;57 (&#x02212;&#x02009;354.38, 240.40)</td></tr><tr><td colspan="2">Week 7: &#x02212;53 (&#x02212;&#x02009;352.70, 246.70)</td></tr><tr><td colspan="2">Week 8: &#x02212;19.00 (&#x02212;&#x02009;394.15, 356.15)</td></tr><tr><td>Difference in gain in length at week 8, mm</td><td colspan="2">4.40&#x000a0;mm, 30% greater gain (<italic>p</italic>&#x000a0;&#x0003c;&#x02009;0.03)<sup>xxvi</sup></td></tr><tr><td rowspan="4">&#x02003;Baqui 2002 [<xref ref-type="bibr" rid="CR27">27</xref>]</td><td rowspan="4">ORS with 20&#x000a0;mg zinc per day, 14&#x000a0;days</td><td rowspan="4">ORS only</td><td rowspan="2">Incidence of diarrhea during 2&#x000a0;year follow up</td><td>RR (95% CI)</td><td>0.85 (0.76, 0.96)</td></tr><tr><td>RD (95% CI)<sup>xxvii</sup></td><td>2.9 (0.80, 5.10)<sup>xxviii</sup></td></tr><tr><td rowspan="2">Mortality during 2&#x000a0;year follow up</td><td>RR (95% CI)</td><td>0.49 (0.25, 0.94)</td></tr><tr><td>RD (95% CI)</td><td>2.2 (0.60, 3.70)<sup>xxix</sup></td></tr><tr><td rowspan="13">&#x02003;Walker 2007 [<xref ref-type="bibr" rid="CR53">53</xref>]</td><td rowspan="13">ORS with 10&#x000a0;mg zinc, 14&#x000a0;days</td><td rowspan="13">ORS with placebo</td><td rowspan="2">Difference in weight at week 4 and 8, kg (95% CI)</td><td colspan="2">Week 4: 0.06 (&#x02212;0.08, 0.20)</td></tr><tr><td colspan="2">Week 8: 0.06 (&#x02212;&#x02009;0.08, 0.20)</td></tr><tr><td rowspan="2">Difference in length at week 4 and 8, cm (95% CI)</td><td colspan="2">Week 4: &#x02212;0.09 (&#x02212;&#x02009;0.61, 0.43)</td></tr><tr><td colspan="2">Week 8: &#x02212;0.12 (&#x02212;&#x02009;0.63, 0.39)</td></tr><tr><td>Proportion of infants with &#x02265;1 episode of any diarrhea (RR [95% CI])<sup>xxx</sup></td><td colspan="2">1.01 (0.92, 1.12)</td></tr><tr><td>Proportion of infants with &#x02265;2 episode of any diarrhea (RR [95% CI])</td><td colspan="2">0.79 (0.67, 0.95)<sup>xxxi</sup></td></tr><tr><td>Proportion of infants with &#x02265;1 episode of dysentery (any day with blood in the stool) (RR [95% CI])</td><td colspan="2">2.10 (0.96, 4.61)</td></tr><tr><td rowspan="2">Incidence of diarrhea (episodes/month)</td><td>Intervention group (mean&#x02009;&#x000b1;&#x02009;SD)</td><td>0.62&#x02009;&#x000b1;&#x02009;0.68</td></tr><tr><td>Control group (mean&#x02009;&#x000b1;&#x02009;SD)</td><td>0.61&#x02009;&#x000b1;&#x02009;0.70</td></tr><tr><td rowspan="2">Prevalence of diarrhea (days/mo)</td><td>Intervention group (mean&#x02009;&#x000b1;&#x02009;SD)</td><td>2.68&#x02009;&#x000b1;&#x02009;4.11</td></tr><tr><td>Control group (mean&#x02009;&#x000b1;&#x02009;SD)</td><td>2.20&#x02009;&#x000b1;&#x02009;3.19</td></tr><tr><td rowspan="2">Mortality</td><td>RR (95% CI)</td><td>0.99 (0.01, 77.9)</td></tr><tr><td>RD (95% CI)<sup>xxxii</sup></td><td>&#x02212;0.18 (&#x02212;66.42, 66.06)</td></tr><tr><td rowspan="5">&#x02003;Roy 2007 [<xref ref-type="bibr" rid="CR28">28</xref>]</td><td rowspan="5">Multivitamin with 10&#x000a0;mg zinc per 5&#x000a0;ml, 14&#x000a0;days</td><td rowspan="5">Multivitamin only</td><td>Difference in mean number of diarrhea episodes during 6 mo follow up (95% CI)<sup>xxxiii</sup></td><td colspan="2">&#x02212;&#x02009;0.33 (&#x02212;&#x02009;0.39, &#x02212;&#x02009;0.27)</td></tr><tr><td rowspan="2">Percent gain in length at 12&#x000a0;weeks, mm<sup>xxxiv</sup></td><td colspan="2">Comparable between groups when all patient were compared (<italic>p</italic>&#x000a0;=&#x02009;0.6)</td></tr><tr><td colspan="2">24% greater among underweight (WAZ&#x02009;&#x02264;&#x02009;70% NCHS median) (p&#x02009;&#x0003c;&#x02009;0.03)</td></tr><tr><td rowspan="2">Mortality</td><td>RR (95% CI)</td><td>0.84 (0.29,2.37)</td></tr><tr><td>RD (95% CI)</td><td>&#x02212;0.01 (&#x02212;0.10, 0.07)</td></tr><tr><td>&#x02003;Roy 2008 [<xref ref-type="bibr" rid="CR29">29</xref>]</td><td>Multivitamin with 20&#x000a0;mg zinc, 14&#x000a0;days</td><td>Multivitamin only</td><td>Geometric mean diarrhea incidence</td><td colspan="2">Statistically significantly higher in control group (<italic>p</italic>&#x000a0;=&#x02009;0.03)</td></tr><tr><td rowspan="2">&#x02003;Fajolu 2008 [<xref ref-type="bibr" rid="CR48">48</xref>]</td><td rowspan="2">20&#x000a0;mg zinc for patients &#x0003e;&#x02009;1 y; 10&#x000a0;mg zinc for patients &#x0003c;&#x02009;1 y</td><td rowspan="2">Placebo</td><td>Number of subsequent diarrhea episodes during 2&#x000a0;month follow up</td><td colspan="2">Difference not significant (<italic>p</italic>&#x000a0;=&#x02009;0.53)</td></tr><tr><td>Weight gain at 2&#x000a0;months, g</td><td colspan="2">Higher in intervention group (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001)</td></tr><tr><td rowspan="4">&#x02003;Larson 2010 [<xref ref-type="bibr" rid="CR30">30</xref>]</td><td rowspan="4">10&#x000a0;days therapeutic zinc (20&#x000a0;mg) followed by 3 mo supplementary zinc (10&#x000a0;mg)</td><td rowspan="4">10&#x000a0;days therapeutic zinc (20&#x000a0;mg) followed by 3 mo supplementary zinc placebo</td><td>Diarrhea episodes during follow up,<sup>xxxv</sup> months 1&#x02013;3 Risk Difference, [95% CI])</td><td colspan="2">&#x02212;1.02 (0.26, 1.79)</td></tr><tr><td>Diarrhea episodes during follow up, months 4&#x02013;6 (Risk Difference, [95% CI])</td><td colspan="2">&#x02212;0.37 (&#x02212;&#x02009;0.35, 1.07)</td></tr><tr><td>Diarrhea episodes during follow up, months 7&#x02013;9 (Risk Difference, [95% CI])</td><td colspan="2">&#x02212;0.18 (&#x02212;&#x02009;0.41, 0.75)</td></tr><tr><td>Diarrhea episodes during entire 9&#x000a0;month follow up (Risk Difference, [95% CI])</td><td colspan="2">&#x02212;0.54 (0.07, 1.01)</td></tr><tr><td rowspan="6">&#x02003;Alam 2011 [<xref ref-type="bibr" rid="CR31">31</xref>]</td><td rowspan="6">Short course zinc &#x02013; 20&#x000a0;mg zinc, 5&#x000a0;days</td><td rowspan="6">Standard course zinc &#x02013; 20&#x000a0;mg zinc, 10&#x000a0;days</td><td>Difference in mean number of diarrhea episodes during 3&#x000a0;month follow up (95% CI)</td><td colspan="2">0.06 (&#x02212;&#x02009;0.07, 0.19)</td></tr><tr><td>Difference in mean number of days of diarrhea during 3&#x000a0;month follow up (95% CI)</td><td colspan="2">0.2 (&#x02212;0.35, 0.75)</td></tr><tr><td>Proportion of children with at least 1 episode of diarrhea during 3&#x000a0;month follow up (RR [95% CI])</td><td colspan="2">1.03 (0.95, 1.14)</td></tr><tr><td>Proportion of children with prolonged diarrhea (&#x02265; 7&#x000a0;days) (Prevalence Ratio [95% CI])<sup>xxxvi</sup></td><td colspan="2">0.63 (0.50, 0.79)</td></tr><tr><td>Proportion of children with persistent diarrhea (&#x02265; 14&#x000a0;days) (Prevalence Ratio [95% CI])</td><td colspan="2">0.63 (0.48, 0.81)</td></tr><tr><td>Day of onset of first subsequent diarrhea episode during follow up</td><td colspan="2">No difference between groups<sup>xxxvii</sup></td></tr><tr><td rowspan="14">&#x02003;Patel 2013 [<xref ref-type="bibr" rid="CR32">32</xref>]</td><td rowspan="14">Zinc (2&#x000a0;mg/kg/day) or zinc + copper (Zn 2&#x000a0;mg/kg/day + Cu 0.2&#x000a0;mg/kg/day), 14&#x000a0;days</td><td rowspan="14">Placebo</td><td rowspan="2">Proportion with at least 1 diarrhea episode during 3&#x000a0;month follow up (Prevalence Ratio [95% CI])</td><td>Zinc group vs placebo</td><td>1.01 (0.76, 1.33)</td></tr><tr><td>Zinc + Copper group vs placebo</td><td>0.96 (0.72, 1.27)</td></tr><tr><td rowspan="2">Proportion with at least 2 episodes of diarrhea during 3&#x000a0;month follow up<sup>xxxviii</sup> (Prevalence Ratio [95% CI])</td><td>Zinc group vs placebo</td><td>2.25 (1.10, 4.63)</td></tr><tr><td>Zinc group vs Zinc + Copper group</td><td>1.12 (0.64, 1.97)</td></tr><tr><td rowspan="2">Proportion with at least 1 dysentery episode during 3&#x000a0;month follow up (Prevalence Ratio[95% CI])</td><td>Zinc group vs placebo</td><td>1.31 (0.30, 5.77)</td></tr><tr><td>Zinc group vs Zinc + Copper group</td><td>1.37 (0.31, 6.04)</td></tr><tr><td rowspan="2">Difference in mean number of subsequent diarrhea episodes per child during 3&#x000a0;month follow up (95% CI)</td><td>Zinc group vs placebo</td><td>0.08 (&#x02212;0.05, 0.21)</td></tr><tr><td>Zinc + copper group vs placebo</td><td>0.05 (&#x02212;0.07, 0.17)</td></tr><tr><td rowspan="2">Difference in change in WAZ at month 3 (95% CI)</td><td>Zinc group vs placebo</td><td>&#x02212;0.1 (&#x02212;&#x02009;0.12, 0.10)</td></tr><tr><td>Zinc + copper group vs placebo</td><td>0.06 (&#x02212;0.04, 0.16)</td></tr><tr><td rowspan="2">Difference in change in WHZ at month 3 (95% CI)</td><td>Zinc group vs placebo</td><td>&#x02212;0.01 (&#x02212;&#x02009;0.18, 0.16)</td></tr><tr><td>Zinc + copper group vs placebo</td><td>0.09 (&#x02212;0.07, 0.25)</td></tr><tr><td rowspan="2">Difference in change in HAZ at month 3 (95% CI)</td><td>Zinc group vs placebo</td><td>0.02 (&#x02212;0.09, 0.13)</td></tr><tr><td>Zinc + copper group vs placebo</td><td>0.03 (&#x02212;0.08, 0.14)</td></tr><tr><td rowspan="2">&#x02003;Negi 2015 [<xref ref-type="bibr" rid="CR33">33</xref>]</td><td rowspan="2">Zinc (20&#x000a0;mg/day) for 14&#x000a0;days</td><td rowspan="2">Placebo</td><td rowspan="2">Risk of having at least 1 episode of diarrhea during 3 mo follow up (Relative risk [95%])</td><td>Among all subjects</td><td>0.65 (0.37, 1.23)</td></tr><tr><td>Among zinc-deficient subjects (<italic>n</italic>&#x000a0;=&#x02009;60)</td><td>0.65 (0.31, 1.38)</td></tr></tbody></table><table-wrap-foot><p><sup>i</sup>Estimate may be interpreted as 11 fewer deaths per 100 children in the intervention group compared to the control group</p><p><sup>ii</sup>Quantitative estimates not presented and reported p-values not specific to time-points of interest</p><p><sup>iii</sup>Data presented were assumed to be mean &#x000b1; SD</p><p><sup>iv</sup>Duration of diets was variable. Diets were started at low concentrations and were advanced every 48 hours if no sign of intolerance. If there were signs of intolerance, diets were maintained or decreased as necessary. When full concentrations were reached, the diet was given for an additional 7 days.</p><p><sup>v</sup>Appropriate data for calculation of weight gain or difference in weight gain not presented</p><p><sup>vi</sup>Defined as when diarrhea had ceased and patient had consistent weight gain for at least 48 hours</p><p><sup>vii</sup>All outcome measurements were compared against measurements at entry, when the child had had diarrhea for 14 days</p><p><sup>viii</sup>Units were assumed to be cm/y due to description of results in the manuscript (rather than (cm/y)2 as presented in the study&#x02019;s Four)</p><p><sup>ix</sup>Defined as age- and sex-specific weight standard deviation scores, from the National Center for Health Statistics median value</p><p><sup>x</sup>No quantitative estimates given</p><p><sup>xi</sup>All diets were equivalent in caloric and protein content</p><p><sup>xii</sup>No estimate or statistical significance given</p><p><sup>xiii</sup>No estimate or statistical significance given</p><p><sup>xiv</sup>No estimates or statistical significance is given</p><p><sup>xv</sup>Confidence interval states in manuscript is (0.605, 0.090) which does not contain the relative risk estimate of 0.812 therefore have assumed the 0.090 was a typo and replaced with 1.090.</p><p><sup>xvi</sup>No estimates or statistical significance given</p><p><sup>xvii</sup>RR was undefined due to a &#x0201c;0&#x0201d; cell</p><p><sup>xviii</sup>The authors changed the dose after 417 children were enrolled (dosages listed, analyzed as "standard strata" of subjects), and the remaining 273 children received a higher dose of zinc (analyzed as "high dose strata"): Vitamin A (4500 ug retinol equivalent daily for 15 days) and/or zinc acetate (40 mg daily for 15 days)</p><p><sup>xix</sup>Results from comparison of zinc+vitamin A vs. placebo not reported (reported on zinc effect by combing the zinc alone and zinc+vitamin A group and reported on vitamin A effect by combining vitamin A alone with the zinc+vitamin A group).</p><p><sup>xx</sup>Vitamin A dosage was 100000 IU for children &#x0003c; 1 yo, and 200000 for children &#x0003e; 1 yo</p><p><sup>xxi</sup>No SDs or CIs given for differences. P-value for the difference between zinc group and control is 0.045; for the difference between vitamin A group and control is 0.207; and for the difference between zinc + vitamin A group is 0.074.</p><p><sup>xxii</sup>Duration of intervention is unclear</p><p><sup>xxiii</sup>Data were presented but were not interpretable due to an ambiguous or incorrect title</p><p><sup>xxiv</sup>Assessed by proportion of patients with delayed recovery, with recovery defined as the passage of formed stool followed by 2 days without diarrhea</p><p><sup>xxv</sup>For this and all outcomes, data were not labeled. Data presented were assumed to be mean and SD based on labeled data on another figure in the paper</p><p><sup>xxvi</sup>No SDs or CIs given. P&#x0003c; 0.05.</p><p><sup>xxvii</sup>Difference in mean diarrhea incidence rates. Estimate may be interpreted as 2.9 more episodes per 100 child-years of observation were experienced in the control group compared to the intervention group</p><p><sup>xxviii</sup>Calculated values of lower and upper limits of 95% CI differed from what was represented in original publication</p><p><sup>xxix</sup>Difference in mean mortality rates. Estimate may be interpreted as 2.2 more deaths per 1000 child years of observation experienced by the control group compared to the intervention group</p><p><sup>xxx</sup>All data presented are unadjusted. The authors&#x02019; results are discrepant from this table&#x02019;s results, as authors adjust for original diarrhea episode lasting &#x0003e; 7 days, exclusive breastfeeding upon enrollment, and WLZ at beginning of follow up</p><p><sup>xxxi</sup>Calculated values of lower and upper limits of 95% CI use data presented on unadjusted proportions and differed from what was represented in original publication</p><p><sup>xxxii</sup>Estimate may be interpreted as 0.18 deaths fewer in intervention group per 100,000 child-weeks of observation compared to control group</p><p><sup>xxxiii</sup>Data presented was assumed to be mean &#x000b1; SD</p><p><sup>xxxiv</sup>Quantitative estimates not presented</p><p><sup>xxxv</sup>Risk differences may be interpreted as excess number of acute diarrhea episodes per child-year attributed to lack of zinc supplementation</p><p><sup>xxxvi</sup>The authors reported "The proportion of prolonged (&#x0003e;=7 d) and persistent diarrhea episodes (&#x0003e;=14 d) did not vary between the 5-d (19 vs. 16%; P 0.08) and 10-d (12 vs. 10%; P = 0.14) groups" which suggests the p-values correspond to the comparison of persistent and prolonged among children treated with 5-days and among children treated with 10-days. We have instead assumed the appropriate comparisons are proportion of prolonged (19% vs. 12%, p-value=0.0001) and persistent (16% vs. 10%, p-value=0.0004) which would result in statistically significant differences (unlike what was reported).</p><p><sup>xxxvii</sup>No estimates or statistical significance given</p><p><sup>xxxviii</sup>Estimates calculated for relative risk of at least 1, 2, or dysenteric diarrhea episodes are discrepant from published results</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec5"><title>Growth</title><p id="Par32">Studies reported impact on growth in several different ways:<list list-type="bullet"><list-item><p id="Par33">
<italic>Height/Length, HAZ//LAZ</italic>
</p></list-item></list></p><p id="Par34">Ten studies presented data related to length or height, with follow-up time ranging from 21&#x000a0;days to 9&#x000a0;months and none reported sample size calculations/being powered for these outcomes (Table <xref rid="Tab1" ref-type="table">1</xref>). Five trials evaluated a high protein diet, 4 therapeutic zinc and 1 probiotic. Of 4 studies that reported difference in&#x000a0;change in (&#x02206;)&#x000a0;HAZ/LAZ between intervention groups, 1 high protein diet trial reported a 0.9 z-score greater gain in HAZ/LAZ in the intervention group after 3&#x000a0;weeks of follow-up (95% CI: 0.05, 0.13), [<xref ref-type="bibr" rid="CR11">11</xref>] but 2 high protein diet trials (with 3 and 29&#x000a0;weeks of follow-up) and a large zinc with 12&#x000a0;weeks of follow-up trial found no significant benefit (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a</xref>) [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. Four studies presented data on &#x02206; absolute height at follow-up, 2 of which were trials of high protein diets with follow-up times of 3 and 29&#x000a0;weeks. Of the 2 high protein diet trials, the trial&#x000a0;with 29&#x000a0;weeks of follow-up found a benefit in height change (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>) &#x02013; a 1.10&#x000a0;cm greater change in height compared to the control groups (95% CI: 0.56, 1.64) [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Of the other 2 studies evaluating height attainment, a trial of a high protein diet with micronutrients with 36&#x000a0;weeks of follow-up, and another of therapeutic zinc with 8&#x000a0;weeks of follow-up, only the former showed benefit (a greater gain in height of 0.65&#x000a0;cm in the intervention group [95% CI: 0.11, 1.19]) [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]. Percent &#x02206;length was evaluated in 2 therapeutic zinc studies, both of which found a significantly greater length gain among children treated with zinc, but this result was only among underweight children in 1 of the trials [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. Among 2 studies evaluating prevalence of stunting during follow-up, 1 found that the group treated with probiotic<italic>s (L. rhamnosus</italic> GG) had higher stunting prevalence at 4&#x000a0;weeks of follow-up [<xref ref-type="bibr" rid="CR54">54</xref>] and a high protein diet trial reported no significant difference at 26&#x000a0;weeks [<xref ref-type="bibr" rid="CR44">44</xref>].<list list-type="bullet"><list-item><p id="Par35">
<italic>MUAC</italic>
</p></list-item></list><fig id="Fig3"><label>Fig. 3</label><caption><p><bold>a</bold> Effect of diarrhea management interventions on change in HAZ/LAZ (difference in change in HAZ/LAZ and 95% confidence interval). <bold>b</bold> Effect of diarrhea management interventions on change in height (difference in change in height (cm) and 95% confidence interval)</p></caption><graphic xlink:href="12889_2018_5092_Fig3_HTML" id="MO3"/></fig></p><p id="Par36">Four studies reported MUAC data during follow-up periods ranging from 15 to 28&#x000a0;days, 2 were high protein studies, 1 was a trial of therapeutic zinc, and 2 trials of RUTF/micronutrient (which assessed MUAC as 1 of the indicators of acute malnutrition). One of the high protein diet studies reported that children in the intervention group gained 0.44&#x000a0;cm more in MUAC on average compared to children given a standard protein diet (95% CI: 0.08, 0.80) [<xref ref-type="bibr" rid="CR10">10</xref>]. However, neither the remaining high protein diet study nor the zinc trial reported a significant difference in MUAC during follow-up [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. None of the studies provided sample size estimates making it unclear whether they were adequately powered to detect differences in MUAC. Both trials of RUTF and micronutrient powder reported the incidence of acute malnutrition (WHZ&#x02009;&#x0003c;&#x02009;2, MUAC &#x0003c;&#x02009;115&#x000a0;mm, or oedema) to be similar across all combinations of groups (RUTF vs controls; micronutrients vs. controls, and RUTF vs. micronutrients) in the subgroup of children from both trials who had diarrhea at enrollment [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>].<list list-type="bullet"><list-item><p id="Par37">
<italic>WHZ, WAZ, or absolute weight</italic>
</p></list-item></list></p><p id="Par38">Thirty-two trials (74.4%) with follow-up periods ranging from 7&#x000a0;days to 29&#x000a0;weeks, reported data on weight, WAZ, or WHZ. Of these, 9 assessed a high protein diet, 7 assessed therapeutic zinc (including 1 which also assessed vitamin A), and 5 tested lactose-free diets. Four were trials of ORS formulations, 3 of probiotics, and 1 each of semi-elemental diet, glutamine, and dietary fiber. Of the 4 trials evaluating differences in &#x02206;WAZ between study groups, 3 high protein and 1 therapeutic zinc trials, 2 (both high protein) reported a statistically significant improvement (ranging from 0.23 [<xref ref-type="bibr" rid="CR11">11</xref>] to 0.3 z-scores [<xref ref-type="bibr" rid="CR10">10</xref>]) compared to a standard diet (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4a</xref>) although none were explicitly powered for this outcome. The same 2 diet trials also reported a significant benefit in WHZ, with high protein groups gaining 0.25 [<xref ref-type="bibr" rid="CR31">31</xref>] to 0.4&#x000a0;units [<xref ref-type="bibr" rid="CR11">11</xref>] more in WHZ than the standard diet group (Fig. <xref rid="Fig4" ref-type="fig">4b</xref>) whereas the 2 zinc trials assessing &#x02206;WHZ, 1 of which was explicitly powered to address WHZ, found no difference [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]. Two additional trials assessed WHZ although did not present quantitative results for calculation of effect size and 95% confidence intervals; A probiotics trial concluded there was no difference in &#x02206;WHZ at 6&#x000a0;weeks between the treated and untreated groups, [<xref ref-type="bibr" rid="CR19">19</xref>] while a high protein diet trial reported a greater median &#x02206;WAZ in children given high protein diets at 26&#x000a0;weeks of follow-up [<xref ref-type="bibr" rid="CR44">44</xref>].<fig id="Fig4"><label>Fig. 4</label><caption><p><bold>a</bold> Effect of diarrhea management interventions on change in WAZ (difference in change in WAZ and 95% confidence interval). <bold>b</bold> Effect of diarrhea management interventions on change in WHZ/WLZ (difference in change in WHZ/WLZ and 95% confidence interval). <bold>c</bold> Effect of diarrhea management interventions on weight gain (difference in weight gain [g] and 95% confidence interval). <bold>d</bold> Effect of diarrhea management interventions on weight at follow up (difference in weight [kg] and 95% confidence interval)</p></caption><graphic xlink:href="12889_2018_5092_Fig4_HTML" id="MO4"/></fig></p><p id="Par39">Twenty-two studies presented data on absolute weight gain (Fig. <xref rid="Fig4" ref-type="fig">4c</xref>) or weight at follow-up: 6 high protein diet trials, 6 zinc (1 of which also assessed vitamin A), 4 lactose free diets, 2 ORS, and 1 each of a probiotic, semi-elemental diet, dietary fiber, and glutamine. Three of the 6 high protein trials found a statistically significant improvement in weight associated with the intervention group, [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>] as did 3 of the 6 zinc trials, [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR48">48</xref>] 1 of which also assessed vitamin A which did not appear to have a weight benefit [<xref ref-type="bibr" rid="CR22">22</xref>]. Two of the 4 lactose-free diets [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR50">50</xref>] and 1 of 2 ORS trials demonstrated a significant benefit in weight [<xref ref-type="bibr" rid="CR39">39</xref>]. This trial found a greater percent improvement in weight 14&#x000a0;days after presentation in the groups of children treated with ORS (90&#x000a0;mmol/l or 50&#x000a0;mmol/l of sodium) vs. no ORS but did not find a statistically significant difference when measured as absolute difference in weight. Weight gain was significantly improved in the trial of a semi-elemental diet [<xref ref-type="bibr" rid="CR35">35</xref>] and the single trial of glutamine found intervention children to have 130&#x000a0;g more weight gain than the placebo group at follow-up day 30, but not at days 60 or 90 of follow-up [<xref ref-type="bibr" rid="CR51">51</xref>]. The single dietary fiber and probiotic trials evaluating weight gain did not find a significant effect [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR47">47</xref>].</p></sec><sec id="Sec6"><title>Recurrent or prolonged diarrhea at follow-up</title><p id="Par40">Twenty studies (45.7% of total) reported on diarrhea frequencies during follow-up periods ranging from 7&#x000a0;days to 3&#x000a0;months. The majority were trials of therapeutic zinc (13), including 2 that also assessed vitamin A, followed by probiotic trials (3), ORS formulation (3 comparisons in 2 trials) and 1 diet fiber and 1 lactose-free diet. Only 4 of the trials explicitly described being powered to address diarrhea prevalence or incidence during follow-up [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]. Figure&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref> shows the 12 trials (providing 15 estimates due to 3 trials including 3 arms) that reported data on prevalence of diarrhea 7&#x000a0;days or more after presentation (8 zinc [2 of which also assessed vitamin A], 2 ORS (1 of which compared 3 formulations), and 2 probiotic). Only 2 zinc studies [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR31">31</xref>] and 1 probiotic (<italic>Saccharomyces boulardii</italic>) trial found a reduction in diarrhea prevalence associated with the intervention [<xref ref-type="bibr" rid="CR41">41</xref>]. The other 6 zinc trials [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR32">32</xref>&#x02013;<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR53">53</xref>] and probiotic trial of <italic>Lactobacillus rhamnosus</italic> GG [<xref ref-type="bibr" rid="CR54">54</xref>] did not find a significant effect on diarrhea prevalence during follow-up. The lactose-free diet reported no effect on the presence of diarrhea at day 12 (<italic>p</italic>&#x000a0;=&#x02009;0.76) but did not report specific prevalences [<xref ref-type="bibr" rid="CR17">17</xref>]. The 2 trials assessing ORS formulations (providing 3 estimates) did not demonstrate a benefit [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR55">55</xref>] nor did the 2 vitamin A trials [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR34">34</xref>].<fig id="Fig5"><label>Fig. 5</label><caption><p>Effect of diarrhea management interventions on diarrhea morbidity during follow up (relative risk or prevalence ratio of diarrhea at specified time during follow up [95% CI])</p></caption><graphic xlink:href="12889_2018_5092_Fig5_HTML" id="MO5"/></fig></p><p id="Par41">Of studies reporting on diarrhea frequency indicators other than prevalence of diarrhea at follow-up, findings were heterogeneous. One study found that children given a rice-based diet with green banana or pectin (dietary fiber) were more likely to have recovered from diarrhea by day 5 of follow-up, while most children given the rice-based diet alone continued to have diarrhea until day 10 of follow-up [<xref ref-type="bibr" rid="CR15">15</xref>]. Another found no children treated with <italic>Lactobacillus reuteri</italic> 17938 to have diarrhea beyond 7-days whereas 17.4% of children without probiotic treatment did have prolonged diarrhea [<xref ref-type="bibr" rid="CR52">52</xref>]. A trial of 8070 community-based children found that those given zinc with ORS had 2.9 fewer episodes of diarrhea per 100 child-years (95%CI: 0.8, 5.1) than those given ORS alone [<xref ref-type="bibr" rid="CR27">27</xref>]. A study contrasting 10 day therapeutic zinc (20&#x000a0;mg/day) with 3&#x000a0;months of supplemental zinc (10&#x000a0;mg/day) to the therapeutic zinc course alone found that the long term zinc reduced diarrhea incidence over a 9&#x000a0;month period by 21% (2.05 vs.2.59 episodes / child years) [<xref ref-type="bibr" rid="CR30">30</xref>]. Compared to children given the multivitamin alone,&#x000a0;children given a multivitamin with zinc had an average of 0.33 fewer subsequent diarrhea episodes (95% CI: -0.39, &#x02212;&#x02009;0.27) and diarrhea incidence&#x000a0;was&#x000a0;similarly reduced in the 6&#x000a0;month follow-up&#x000a0;period [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Conversely, a placebo-controlled trial of therapeutic zinc among 1042 children reported no difference in the mean number of subsequent diarrhea episodes during a 3&#x000a0;month follow-up period nor did 2 smaller zinc trials [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR48">48</xref>].</p></sec></sec><sec id="Sec7"><title>Discussion</title><p id="Par42">While significant progress has been made over the past 25&#x000a0;years in reducing deaths attributed to diarrhea, there is increasing recognition that diarrhea is associated with mortality, subsequent morbidities, and malnutrition in the period after a diarrheal episode [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. These post-acute sequelae highlight the need, and opportunity, to identify interventions to reduce morbidity and mortality among children presenting with diarrhea. This systematic review appraised diarrhea intervention trials for evidence of effects on post-acute sequelae of diarrhea, including mortality, nutritional status, and diarrhea presence during an extended follow-up period.</p><p id="Par43">We found very few trials that evaluated post-acute diarrheal mortality, and only 1 (of zinc) was explicitly powered to address mortality and found mortality benefit [<xref ref-type="bibr" rid="CR27">27</xref>]. The&#x000a0;other zinc trials did not report a mortality benefit. As summarized in a recent Cochrane review, zinc appears to reduce diarrhea duration, particularly in malnourished children, although the degree to which this effect translates to mortality benefit remains unknown [<xref ref-type="bibr" rid="CR58">58</xref>]. Therapeutic zinc also appears to have limited to no efficacy on morbidity or growth in children under 6&#x000a0;months of age [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR59">59</xref>].</p><p id="Par44">Post-acute mortality was assessed in 2 trials of antibiotics that found no mortality benefit, yet were underpowered to do so. Both trials included less than 100 children and only 1 was placebo-controlled. The role of antibiotics in diarrhea management remains controversial. In the absence of diagnostics, diarrhea management guidelines recommend antibiotics only for dysentery or suspected cholera [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]. Limiting antibiotics to these 2 indications may miss other serious enteric infections amenable to antibiotics [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. In practice however, many children without these indications are treated with an antibiotic, the benefits of which are not well understood [<xref ref-type="bibr" rid="CR64">64</xref>]. Large placebo-controlled clinical trials are needed to determine the potential harm and/or benefit of antibiotics to reduce post-acute diarrhea morbidity and mortality.</p><p id="Par45">Over 30 trials reported on growth outcomes. Dietary supplementation with macro- or micro-nutrients, high protein and lactose-free diets, and probiotics were assessed for effects on growth&#x000a0;with mixed results. We found substantial variability in how growth outcomes were evaluated, making comparisons between studies challenging. Two of the 5 trials of dietary interventions found beneficial impacts on WAZ/WHZ with a high protein isocaloric diet. In a single study, glutamine demonstrated a signal of benefit at 1 time point which was not sustained. Most trials that assessed weight reported no intervention effect; perhaps because weight gain restored through hydration during the acute phase of diarrhea overshadowed weight gain from trialed interventions. High protein diets, either alone or in combination with micronutrients such as zinc, had a modest impact on short to medium term linear growth (3&#x000a0;weeks to 9&#x000a0;months). However, this effect was inconsistently demonstrated. High protein diets may restore the protein loss that can occur during and immediately after infection [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>]. Replacing protein may modify growth consequences of diarrhea by increasing protein availability or by influencing hormonal regulation [<xref ref-type="bibr" rid="CR67">67</xref>&#x02013;<xref ref-type="bibr" rid="CR69">69</xref>]. The combination of high protein and zinc may restore integrity of damaged mucosal surfaces and improve nutrient absorption [<xref ref-type="bibr" rid="CR70">70</xref>&#x02013;<xref ref-type="bibr" rid="CR72">72</xref>]. However evidence around the effect of zinc on markers of intestinal permeability, as measured by the lactulose to mannitol ratio, are inconsistent [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>]. Specific amino acids may also be important; glutamine has been shown to protect against bacterial translocation through maintenance of the gut barrier in animal models [<xref ref-type="bibr" rid="CR75">75</xref>&#x02013;<xref ref-type="bibr" rid="CR77">77</xref>].</p><p id="Par46">Diarrhea during follow-up was the most commonly reported outcome assessed in this review. Numerous systematic reviews of therapeutic zinc on diarrheal outcomes have been conducted, all of which suggest some benefit [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR78">78</xref>&#x02013;<xref ref-type="bibr" rid="CR80">80</xref>]. The effects of zinc on diarrhea at a specified day of follow-up were recently summarized in a Cochrane review and pooled relative risks of diarrhea at day 3, day 5, and day 7 associated with zinc all showed a statistically significant benefit [<xref ref-type="bibr" rid="CR58">58</xref>]. Our review included diarrhea assessed at 7&#x000a0;days and beyond&#x000a0;(7&#x000a0;days to 4&#x000a0;months) and found inconsistent results, perhaps demonstrating a waning in effect or sub-optimal statistical power at longer follow-up time points. Given therapeutic zinc is recommended for 14&#x000a0;days in current WHO management guidelines yet the data on benefit seems most pronounced within the first 7&#x000a0;days, days 7&#x02013;14 of the currently recommended zinc course may need further evaluation.</p><p id="Par47">Three of the 4 probiotic trials evaluating diarrhea outcomes demonstrated a benefit on diarrhea during follow-up (<italic>Saccharomyces boulardii, Lactobacillus reuteri</italic> 17938 and 1 of the 2 <italic>Lactobacillus rhamnosus</italic> GG trials<italic>)</italic>. However the <italic>Lactobacillus rhamnosus</italic> GG trial that did not find a benefit in diarrhea during follow-up did report improvements in intestinal function (as measured by the lactulose to mannitol test) and higher immunoglobulin G (IgG) in the subgroup of children with rotavirus infection treated with the probiotic [<xref ref-type="bibr" rid="CR54">54</xref>]. Most clinical trials&#x000a0;of probiotics have been conducted in high-resource settings and have treated and followed children for less than 7 days [<xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR82">82</xref>].&#x000a0;Although not included in this review&#x000a0;because it was published after the search was conducted, a recent pilot study (n=76)&#x000a0;conducted in Botswana found a greater increase in HAZ and reduced diarrhea recurrence over 60-days of follow-up among admitted children with diarrhea randomized to <italic>Lactobacillus reuteri</italic> 17938, [<xref ref-type="bibr" rid="CR62">62</xref>]. The European Society for Pediatric Gastroenterology recently recommended probiotics, specifically <italic>Saccharomyces boulardii</italic> or <italic>Lactobacillus rhamnosus</italic> GG<italic>,</italic> to reduce the duration and intensity of gastroenteritis [<xref ref-type="bibr" rid="CR83">83</xref>]. The mechanisms by which probiotics may decrease diarrheal symptoms are largely unknown, but may act by out-competing pathogenic enteric infections for nutrients, restoring gut barrier functions, and/or by restoring gut microbial balance.</p><p id="Par48">This review had several limitations. Most trials, particularly trials used to evaluate mortality, were underpowered. A 2-armed clinical trial powered to detect a 50% reduction in a 3-month diarrheal case fatality rate of 2% would require over 4000 participants, a sample size far larger than most trials reporting mortality outcomes in this review and far smaller than sample sizes required to detect smaller intervention effects or lower case fatality rates. Many trials were excluded because of short length of follow-up and included trials had follow-up times ranging from 7-days to 9&#x000a0;months which could explain heterogeneity between studies, particularly studies of growth outcomes. Some interventions were more represented than others based on available clinical trial data. Markers of enteric function were not included in this review as pre-specified outcomes, despite a growing body of evidence suggesting that enteric dysfunction is linked to poor outcomes following acute illness [<xref ref-type="bibr" rid="CR84">84</xref>]. Because of the heterogeneity in interventions, outcome measurements, and follow-up time, we did not calculate pooled measures of effect. For the same reason, we did not report a GRADE score for every individual result but rather for overall study quality, and most trials were graded as low or very low. Standardized measures of the nutritional consequences of diarrhea and diarrhea morbidity will be important to enable future meta-analyses. This review includes data from a wide range of geographic, demographic and epidemiologic settings. However, most included trials were conducted in Asia, with less than 15% of all included trials conducted in sub-Saharan Africa (SSA). Diarrhea-mortality rates are higher in SSA than in South Asia and recent projections of childhood mortality into 2030 predict that SSA will contribute to 60% of all childhood deaths [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. Host characteristics, such as nutritional status and HIV-infection/&#x02212;exposure vary greatly between these regions making generalizability of intervention effect challenging [<xref ref-type="bibr" rid="CR85">85</xref>&#x02013;<xref ref-type="bibr" rid="CR87">87</xref>].</p></sec><sec id="Sec8"><title>Conclusions</title><p id="Par49">In many resource-limited settings, diarrheal episodes in young children are frequent and are associated with increased risk of mortality as well as growth failure and risk of subsequent infections. The mechanisms by which diarrhea and underlying enteric infections lead to morbidity, malnutrition, and mortality are multifactorial, likely requiring multiple complementary interventions to reduce likelihood of recurrence or persistence, promote healing of the gut mucosa, and to replenish lost protein and nutrients. Well-designed, multi-factorial, clinical trials evaluating the extended impact of diarrhea management interventions are urgently needed to reduce the long-term risks associated with diarrhea.</p></sec></body><back><app-group><app id="App1"><sec id="Sec9"><title>Additional file</title><p id="Par56">
<media position="anchor" xlink:href="12889_2018_5092_MOESM1_ESM.docx" id="MOESM1"><label>Additional file 1:</label><caption><p>Supplement. (DOCX 129 kb)</p></caption></media>
</p></sec></app></app-group><glossary><title>Abbreviations</title><def-list><def-item><term>CI</term><def><p id="Par5">Confidence Interval</p></def></def-item><def-item><term>GRADE</term><def><p id="Par6">Grading of Recommendations Assessment Development and Evaluation</p></def></def-item><def-item><term>HAZ</term><def><p id="Par7">Height-for-age z-score</p></def></def-item><def-item><term>LAZ</term><def><p id="Par8">Length-for-age z-score</p></def></def-item><def-item><term>LMICs</term><def><p id="Par9">Low- and middle-income countries</p></def></def-item><def-item><term>MSD</term><def><p id="Par10">Moderate-to-severe diarrhea</p></def></def-item><def-item><term>MUAC</term><def><p id="Par11">Mid upper arm circumference</p></def></def-item><def-item><term>PR</term><def><p id="Par12">Prevalence Ratio</p></def></def-item><def-item><term>RCT</term><def><p id="Par13">Randomized controlled trial</p></def></def-item><def-item><term>RR</term><def><p id="Par14">Relative Risk</p></def></def-item><def-item><term>RUTF</term><def><p id="Par15">Ready-to-use therapeutic foods</p></def></def-item><def-item><term>WAZ</term><def><p id="Par16">Weight-for-age z-score</p></def></def-item><def-item><term>WHZ</term><def><p id="Par17">Weight-for-height z-score</p></def></def-item><def-item><term>WLZ</term><def><p id="Par18">Weight-for-length z-score</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Electronic supplementary material</bold></p><p>The online version of this article (10.1186/s12889-018-5092-7) contains supplementary material, which is available to authorized users.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We would like to thank the Global Center for Integrated Health of Women, Adolescents, and Children, the Kenya Research and Training Center, and the Center for AIDS Research Enterics Working group for their support during the preparation of this article.</p><sec id="FPar1"><title>Funding</title><p id="Par50">Funding was provided by the Bill and Melinda Gates Foundation (OPP1132140) and the UW Global Center for Integrated Health of Women, Adolescents and Children (Global WACh). JLW and DMD are supported by the Childhood Acute Illness and Nutrition Network (CHAIN, OPP1131320). GJS is supported by a National Institute of Health mentoring award (grant number K24- HD054314) and PBP and GJS are supported by the International Core of the University of Washington Center for AIDS Research (CFAR; Seattle, WA, USA), an NIH funded program (P30 AI027757). The funders had no role in the study design, data abstraction, data interpretation, or writing of the manuscript.</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p id="Par51">All data generated or analyzed during this study are included in this published article.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>PBP, JLW, DMD, and GJS conceived of the idea and developed the protocol for this review. All titles and abstracts were screened by PBP and HEA, RLB and HEA reviewed all abstracts and full text articles with final input from PBP. RLB and HEA abstracted data from, and conducted GRADE assessments of, included studies. All authors contributed to the development, reading, and approving the final version for publication.</p></notes><notes notes-type="COI-statement"><sec id="FPar3"><title>Ethics approval and consent to participate</title><p id="Par52">Not applicable</p></sec><sec id="FPar4"><title>Consent for publication</title><p id="Par53">Not applicable</p></sec><sec id="FPar5"><title>Competing interests</title><p id="Par54">The authors declare that they have no competing interests.</p></sec><sec id="FPar6"><title>Publisher&#x02019;s Note</title><p id="Par55">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Oza</surname><given-names>S</given-names></name><name><surname>Hogan</surname><given-names>D</given-names></name><name><surname>Chu</surname><given-names>Y</given-names></name><name><surname>Perin</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Lawn</surname><given-names>JE</given-names></name><name><surname>Cousens</surname><given-names>S</given-names></name><name><surname>Mathers</surname><given-names>C</given-names></name><name><surname>Black</surname><given-names>RE</given-names></name></person-group><article-title>Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the sustainable development goals</article-title><source>Lancet</source><year>2016</year><volume>388</volume><issue>10063</issue><fpage>3027</fpage><lpage>3035</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(16)31593-8</pub-id><?supplied-pmid 27839855?><pub-id pub-id-type="pmid">27839855</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotloff</surname><given-names>KL</given-names></name><name><surname>Nataro</surname><given-names>JP</given-names></name><name><surname>Blackwelder</surname><given-names>WC</given-names></name><name><surname>Nasrin</surname><given-names>D</given-names></name><name><surname>Farag</surname><given-names>TH</given-names></name><name><surname>Panchalingam</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Sow</surname><given-names>SO</given-names></name><name><surname>Sur</surname><given-names>D</given-names></name><name><surname>Breiman</surname><given-names>RF</given-names></name><etal/></person-group><article-title>Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the global enteric multicenter study, GEMS): a prospective, case-control study</article-title><source>Lancet</source><year>2013</year><volume>382</volume><fpage>209</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(13)60844-2</pub-id><?supplied-pmid 23680352?><pub-id pub-id-type="pmid">23680352</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>AE</given-names></name><name><surname>Molla</surname><given-names>M</given-names></name><name><surname>Worku</surname><given-names>A</given-names></name><name><surname>Hurt</surname><given-names>L</given-names></name><name><surname>Kirkwood</surname><given-names>B</given-names></name><name><surname>Mohan</surname><given-names>B</given-names></name><name><surname>Bhutta</surname><given-names>Z</given-names></name><name><surname>Raza</surname><given-names>F</given-names></name><name><surname>Mrema</surname><given-names>S</given-names></name></person-group><article-title>Childhood diarrhoeal deaths in seven low- and middle-income countries</article-title><source>Bull World Health Organ</source><year>2014</year><volume>92</volume><fpage>664</fpage><lpage>671</lpage><pub-id pub-id-type="doi">10.2471/BLT.13.134809</pub-id><?supplied-pmid 25378757?><pub-id pub-id-type="pmid">25378757</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Checkley</surname><given-names>W</given-names></name><name><surname>Buckley</surname><given-names>G</given-names></name><name><surname>Gilman</surname><given-names>RH</given-names></name><name><surname>Assis</surname><given-names>AM</given-names></name><name><surname>Guerrant</surname><given-names>RL</given-names></name><name><surname>Morris</surname><given-names>SS</given-names></name><name><surname>M&#x000f8;lbak</surname><given-names>K</given-names></name><name><surname>Valentiner-Branth</surname><given-names>P</given-names></name><name><surname>Lanata</surname><given-names>CF</given-names></name><name><surname>Black</surname><given-names>RE</given-names></name></person-group><article-title>Multi-country analysis of the effects of diarrhoea on childhood stunting</article-title><source>Int J Epidemiol</source><year>2008</year><volume>37</volume><fpage>816</fpage><lpage>830</lpage><pub-id pub-id-type="doi">10.1093/ije/dyn099</pub-id><?supplied-pmid 18567626?><pub-id pub-id-type="pmid">18567626</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Johnson</surname><given-names>H</given-names></name><name><surname>Cousens</surname><given-names>S</given-names></name></person-group><article-title>Global, regional, and national causes of child mortality in 2000-2010: an updated systematic analysis</article-title><source>Lancet</source><year>2015</year><volume>385</volume><fpage>430</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(14)61698-6</pub-id><?supplied-pmid 25280870?><pub-id pub-id-type="pmid">25280870</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Black</surname><given-names>RE</given-names></name><name><surname>Victora</surname><given-names>CG</given-names></name><name><surname>Walker</surname><given-names>SP</given-names></name><name><surname>Bhutta</surname><given-names>ZA</given-names></name><name><surname>Christian</surname><given-names>P</given-names></name><name><surname>de Onis</surname><given-names>M</given-names></name><name><surname>Ezzati</surname><given-names>M</given-names></name><name><surname>Grantham-McGregor</surname><given-names>S</given-names></name><name><surname>Katz</surname><given-names>J</given-names></name><name><surname>Martorell</surname><given-names>R</given-names></name><etal/></person-group><article-title>Maternal and child undernutrition and overweight in low-income and middle-income countries</article-title><source>Lancet</source><year>2013</year><volume>382</volume><issue>9890</issue><fpage>427</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(13)60937-X</pub-id><?supplied-pmid 23746772?><pub-id pub-id-type="pmid">23746772</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">World Bank Group. Low &#x00026; Middle Income Countries. World Bank. 2016. <ext-link ext-link-type="uri" xlink:href="https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups">https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups</ext-link>.</mixed-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilman</surname><given-names>R</given-names></name><name><surname>Koster</surname><given-names>F</given-names></name><name><surname>Islam</surname><given-names>S</given-names></name><name><surname>McLaughlin</surname><given-names>J</given-names></name><name><surname>Rahaman</surname><given-names>M</given-names></name></person-group><article-title>High- and low-dose Ampicillin therapy for treatment of severe dysentery due to Shigella dysenteriae type 1</article-title><source>Antimicrob Agents Chemother</source><year>1980</year><volume>17</volume><fpage>402</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1128/AAC.17.3.402</pub-id><?supplied-pmid 6999981?><pub-id pub-id-type="pmid">6999981</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Datta</surname><given-names>D</given-names></name><name><surname>Datta</surname><given-names>P</given-names></name><name><surname>Bhattacharya</surname><given-names>SK</given-names></name><name><surname>Mitra</surname><given-names>U</given-names></name><name><surname>Bhattacharya</surname><given-names>MK</given-names></name><name><surname>Sen</surname><given-names>D</given-names></name><name><surname>Sinha</surname><given-names>AK</given-names></name><name><surname>Manna</surname><given-names>B</given-names></name><name><surname>Mitra</surname><given-names>AK</given-names></name><name><surname>Lahiri</surname><given-names>M</given-names></name><etal/></person-group><article-title>Effect of protein rich diet during acute phase of dysentery</article-title><source>Indian J Public Health</source><year>1990</year><volume>34</volume><fpage>1</fpage><lpage>5</lpage><?supplied-pmid 2101381?><pub-id pub-id-type="pmid">2101381</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabir</surname><given-names>I</given-names></name><name><surname>Butler</surname><given-names>T</given-names></name><name><surname>Underwood</surname><given-names>LE</given-names></name><name><surname>Rahman</surname><given-names>MM</given-names></name></person-group><article-title>Effects of a protein-rich diet during convalescence from shigellosis on catch-up growth, serum proteins, and insulin-like growth factor-I</article-title><source>Pediatr Res</source><year>1992</year><volume>32</volume><fpage>689</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1203/00006450-199212000-00014</pub-id><?supplied-pmid 1287560?><pub-id pub-id-type="pmid">1287560</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabir</surname><given-names>I</given-names></name><name><surname>Malek</surname><given-names>M</given-names></name><name><surname>Mazumder</surname><given-names>RN</given-names></name><name><surname>Rahman</surname><given-names>M</given-names></name><name><surname>Mahalanabis</surname><given-names>D</given-names></name></person-group><article-title>Rapid during growth of children fed a high-protein convalescence from shigellosis13</article-title><source>Am J Clin Nutr</source><year>1993</year><volume>57</volume><fpage>441</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1093/ajcn/57.3.441</pub-id><?supplied-pmid 8438780?><pub-id pub-id-type="pmid">8438780</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazumder</surname><given-names>RN</given-names></name><name><surname>Hoque</surname><given-names>SS</given-names></name><name><surname>Ashraf</surname><given-names>H</given-names></name><name><surname>Kabir</surname><given-names>I</given-names></name><name><surname>Wahed</surname><given-names>MA</given-names></name></person-group><article-title>Early feeding of an energy dense diet during acute shigellosis enhances growth in malnourished children</article-title><source>J Nutr</source><year>1997</year><volume>127</volume><fpage>51</fpage><lpage>54</lpage><?supplied-pmid 9040543?><pub-id pub-id-type="pmid">9040543</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabir</surname><given-names>I</given-names></name><name><surname>Rahman</surname><given-names>MM</given-names></name><name><surname>Haider</surname><given-names>R</given-names></name><name><surname>Mazumder</surname><given-names>RN</given-names></name><name><surname>Khaled</surname><given-names>MA</given-names></name><name><surname>Mahalanabis</surname><given-names>D</given-names></name></person-group><article-title>Increased height gain of children fed a high-protein diet during convalescence from shigellosis: a six-month follow-up study</article-title><source>J Nutr</source><year>1998</year><volume>128</volume><fpage>1688</fpage><lpage>1691</lpage><?supplied-pmid 9772137?><pub-id pub-id-type="pmid">9772137</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="other">Mazumder RN, Ashraf H, Hoque SS, Kabir I, Majid N, Wahed MA, Fuchs GJ, Mahalanabis D: Effect of an energy-dense diet on the clinical course of acute shigellosis in undernourished children<bold>.</bold> Br J Nutr 2000, 84:775-779.</mixed-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabbani</surname><given-names>GH</given-names></name><name><surname>Teka</surname><given-names>T</given-names></name><name><surname>Zaman</surname><given-names>B</given-names></name><name><surname>Majid</surname><given-names>N</given-names></name><name><surname>Khatun</surname><given-names>M</given-names></name><name><surname>Fuchs</surname><given-names>GJ</given-names></name></person-group><article-title>Clinical studies in persistent diarrhea: dietary management with green banana or pectin in Bangladeshi children</article-title><source>Gastroenterology</source><year>2001</year><volume>121</volume><fpage>554</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1053/gast.2001.27178</pub-id><?supplied-pmid 11522739?><pub-id pub-id-type="pmid">11522739</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhan</surname><given-names>MK</given-names></name><name><surname>Arora</surname><given-names>NK</given-names></name><name><surname>Khoshoo</surname><given-names>PR</given-names></name><name><surname>Bhatnagar</surname><given-names>S</given-names></name><name><surname>Sazawal</surname><given-names>S</given-names></name><name><surname>Sharma</surname><given-names>K</given-names></name></person-group><article-title>Comparison of a lactose-free cereal-based formula and cow's milk in infants and children with acute gastroenteritis</article-title><source>J Pediatr Gastroenterol Nutr</source><year>1988</year><volume>7</volume><fpage>208</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1097/00005176-198803000-00009</pub-id><?supplied-pmid 3351705?><pub-id pub-id-type="pmid">3351705</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="other">Bhatnagar S, Bhan M, Singh K, Saxena S, Shariff M. Efficacy of milk-based diets in persistent diarrhea- a randomized, controlled trial. Pediatrics. 1996;98</mixed-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>NH</given-names></name><name><surname>Islam</surname><given-names>S</given-names></name><name><surname>Sattar</surname><given-names>S</given-names></name><name><surname>Monira</surname><given-names>S</given-names></name><name><surname>Desjeux</surname><given-names>J-F</given-names></name></person-group><article-title>Safety of rapid intravenous rehydration and comparative efficacy of 3 oral rehydration solutions in the treatment of severely malnourished children with dehydrating cholera</article-title><source>J Pediatr Gastroenterol Nutr</source><year>2009</year><volume>48</volume><fpage>318</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1097/MPG.0b013e318180af27</pub-id><?supplied-pmid 19274788?><pub-id pub-id-type="pmid">19274788</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Misra</surname><given-names>S</given-names></name><name><surname>Sabui</surname><given-names>T</given-names></name><name><surname>Pal</surname><given-names>N</given-names></name></person-group><article-title>A randomized controlled trial to evaluate the efficacy of lactobacillus GG in infantile diarrhea</article-title><source>J Pediatr</source><year>2009</year><volume>155</volume><fpage>129</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2009.01.060</pub-id><?supplied-pmid 19559297?><pub-id pub-id-type="pmid">19559297</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sindhu</surname><given-names>KN</given-names></name><name><surname>Sowmyanarayanan</surname><given-names>TV</given-names></name><name><surname>Paul</surname><given-names>A</given-names></name><name><surname>Babji</surname><given-names>S</given-names></name><name><surname>Ajjampur</surname><given-names>SS</given-names></name><name><surname>Priyadarshini</surname><given-names>S</given-names></name><name><surname>Sarkar</surname><given-names>R</given-names></name><name><surname>Balasubramanian</surname><given-names>KA</given-names></name><name><surname>Wanke</surname><given-names>CA</given-names></name><name><surname>Ward</surname><given-names>HD</given-names></name><etal/></person-group><article-title>Immune response and intestinal permeability in children with acute gastroenteritis treated with lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial</article-title><source>Clin Infect Dis</source><year>2014</year><volume>58</volume><issue>8</issue><fpage>1107</fpage><lpage>1115</lpage><pub-id pub-id-type="doi">10.1093/cid/ciu065</pub-id><?supplied-pmid 24501384?><pub-id pub-id-type="pmid">24501384</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faruque</surname><given-names>AS</given-names></name><name><surname>Hoque</surname><given-names>SS</given-names></name><name><surname>Fuchs</surname><given-names>GJ</given-names></name><name><surname>Mahalanabis</surname><given-names>D</given-names></name></person-group><article-title>Randomized, controlled, clinical trial of rice versus glucose oral rehydration solutions in infants and young children with acute watery diarrhoea</article-title><source>Acta Paediatr</source><year>1997</year><volume>86</volume><fpage>1308</fpage><lpage>1311</lpage><pub-id pub-id-type="doi">10.1111/j.1651-2227.1997.tb14903.x</pub-id><?supplied-pmid 9475306?><pub-id pub-id-type="pmid">9475306</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khatun</surname><given-names>UH</given-names></name><name><surname>Malek</surname><given-names>MA</given-names></name><name><surname>Black</surname><given-names>RE</given-names></name><name><surname>Sarkar</surname><given-names>NR</given-names></name><name><surname>Wahed</surname><given-names>MA</given-names></name><name><surname>Fuchs</surname><given-names>G</given-names></name><name><surname>Roy</surname><given-names>SK</given-names></name></person-group><article-title>A randomized controlled clinical trial of zinc, vitamin a or both in undernourished children with persistent diarrhea in Bangladesh</article-title><source>Acta Paediatr</source><year>2001</year><volume>90</volume><fpage>376</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1080/080352501750126159</pub-id><?supplied-pmid 11332926?><pub-id pub-id-type="pmid">11332926</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sazawal</surname><given-names>S</given-names></name><name><surname>Black</surname><given-names>RE</given-names></name><name><surname>Bhan</surname><given-names>MK</given-names></name><name><surname>Bhandari</surname><given-names>N</given-names></name><name><surname>Sinha</surname><given-names>A</given-names></name><name><surname>Jalla</surname><given-names>S</given-names></name></person-group><article-title>Zinc supplementation in young children with acute diarrhea in India</article-title><source>N Engl J Med</source><year>1995</year><volume>333</volume><fpage>839</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1056/NEJM199509283331304</pub-id><?supplied-pmid 7651474?><pub-id pub-id-type="pmid">7651474</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>SK</given-names></name><name><surname>Tomkins</surname><given-names>AM</given-names></name><name><surname>Mahalanabis</surname><given-names>D</given-names></name><name><surname>Akramuzzaman</surname><given-names>SM</given-names></name><name><surname>Haider</surname><given-names>R</given-names></name><name><surname>Behrens</surname><given-names>RH</given-names></name><name><surname>Fuchs</surname><given-names>G</given-names></name></person-group><article-title>Impact of zinc supplementation on persistent diarrhoea in malnourished Bangladeshi children</article-title><source>Acta Paediatr</source><year>1998</year><volume>87</volume><fpage>1235</fpage><lpage>1239</lpage><pub-id pub-id-type="doi">10.1111/j.1651-2227.1998.tb00943.x</pub-id><?supplied-pmid 9894821?><pub-id pub-id-type="pmid">9894821</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>SK</given-names></name><name><surname>Behrens</surname><given-names>RH</given-names></name><name><surname>Haider</surname><given-names>R</given-names></name><name><surname>Akramuzzaman</surname><given-names>SM</given-names></name><name><surname>Mahalanabis</surname><given-names>D</given-names></name><name><surname>Wahed</surname><given-names>MA</given-names></name><name><surname>Tomkins</surname><given-names>AM</given-names></name></person-group><article-title>Impact of zinc supplementation on intestinal permeability in Bangladeshi children with acute diarrhoea and persistent diarrhoea syndrome</article-title><source>J Pediatr Gastroenterol Nutr</source><year>1999</year><volume>15</volume><fpage>289</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1097/00005176-199210000-00010</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>NH</given-names></name><name><surname>Meier</surname><given-names>R</given-names></name><name><surname>Schneider</surname><given-names>H</given-names></name><name><surname>Sarker</surname><given-names>SA</given-names></name><name><surname>Bardhan</surname><given-names>PK</given-names></name><name><surname>Mahalanabis</surname><given-names>D</given-names></name><name><surname>Fuchs</surname><given-names>GJ</given-names></name><name><surname>Gyr</surname><given-names>N</given-names></name></person-group><article-title>Partially hydrolyzed guar gum-supplemented oral rehydration solution in the treatment of acute diarrhea in children</article-title><source>J Pediatr Gastroenterol Nutr</source><year>2000</year><volume>31</volume><fpage>503</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1097/00005176-200011000-00010</pub-id><?supplied-pmid 11144434?><pub-id pub-id-type="pmid">11144434</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baqui</surname><given-names>AH</given-names></name><name><surname>Black</surname><given-names>RE</given-names></name><name><surname>El Arifeen</surname><given-names>S</given-names></name><name><surname>Yunus</surname><given-names>M</given-names></name><name><surname>Chakraborty</surname><given-names>J</given-names></name><name><surname>Ahmed</surname><given-names>S</given-names></name><name><surname>Vaughan</surname><given-names>JP</given-names></name></person-group><article-title>Effect of zinc supplementation started during diarrhoea on morbidity and mortality in Bangladeshi children: community randomised trial</article-title><source>BMJ</source><year>2002</year><volume>325</volume><issue>7372</issue><fpage>1059</fpage><pub-id pub-id-type="doi">10.1136/bmj.325.7372.1059</pub-id><?supplied-pmid 12424162?><pub-id pub-id-type="pmid">12424162</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>SK</given-names></name><name><surname>Tomkins</surname><given-names>AM</given-names></name><name><surname>Haider</surname><given-names>R</given-names></name><name><surname>Behren</surname><given-names>RH</given-names></name><name><surname>Akramuzzaman</surname><given-names>SM</given-names></name><name><surname>Mahalanabis</surname><given-names>D</given-names></name><name><surname>Fuchs</surname><given-names>GJ</given-names></name></person-group><article-title>Impact of zinc supplementation on subsequent growth and morbidity in Bangladeshi children with acute diarrhoea</article-title><source>Eur J Clin Nutr</source><year>2007</year><volume>53</volume><fpage>529</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1038/sj.ejcn.1600734</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>SK</given-names></name><name><surname>Raqib</surname><given-names>R</given-names></name><name><surname>Khatun</surname><given-names>W</given-names></name><name><surname>Azim</surname><given-names>T</given-names></name><name><surname>Chowdhury</surname><given-names>R</given-names></name><name><surname>Fuchs</surname><given-names>GJ</given-names></name><name><surname>Sack</surname><given-names>DA</given-names></name></person-group><article-title>Zinc supplementation in the management of shigellosis in malnourished children in Bangladesh</article-title><source>Eur J Clin Nutr</source><year>2008</year><volume>62</volume><fpage>849</fpage><lpage>855</lpage><pub-id pub-id-type="doi">10.1038/sj.ejcn.1602795</pub-id><?supplied-pmid 17554249?><pub-id pub-id-type="pmid">17554249</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larson</surname><given-names>CP</given-names></name><name><surname>Nasrin</surname><given-names>D</given-names></name><name><surname>Saha</surname><given-names>A</given-names></name><name><surname>Chowdhury</surname><given-names>MI</given-names></name><name><surname>Qadri</surname><given-names>F</given-names></name></person-group><article-title>The added benefit of zinc supplementation after zinc treatment of acute childhood diarrhoea: a randomized, double-blind field trial</article-title><source>Trop Med Int Health</source><year>2010</year><volume>15</volume><fpage>754</fpage><lpage>761</lpage><pub-id pub-id-type="doi">10.1111/j.1365-3156.2010.02525.x</pub-id><?supplied-pmid 20374562?><pub-id pub-id-type="pmid">20374562</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>DS</given-names></name><name><surname>Yunus</surname><given-names>M</given-names></name><name><surname>El Arifeen</surname><given-names>S</given-names></name><name><surname>Chowdury</surname><given-names>HR</given-names></name><name><surname>Larson</surname><given-names>CP</given-names></name><name><surname>Sack</surname><given-names>DA</given-names></name><name><surname>Baqui</surname><given-names>AH</given-names></name><name><surname>Black</surname><given-names>RE</given-names></name></person-group><article-title>Zinc treatment for 5 or 10 days is equally efficacious in preventing diarrhea in the subsequent 3 months among Bangladeshi children</article-title><source>J Nutr</source><year>2011</year><volume>141</volume><fpage>312</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.3945/jn.110.120857</pub-id><?supplied-pmid 21147907?><pub-id pub-id-type="pmid">21147907</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>AB</given-names></name><name><surname>Dibley</surname><given-names>MJ</given-names></name><name><surname>Mamtani</surname><given-names>M</given-names></name><name><surname>Badhoniya</surname><given-names>N</given-names></name><name><surname>Kulkarni</surname><given-names>H</given-names></name></person-group><article-title>Therapeutic zinc and copper supplementation in acute diarrhea does not influence short-term morbidity and growth: double-blind randomized controlled trial</article-title><source>Pediatr Infect Dis J</source><year>2013</year><volume>32</volume><issue>1</issue><fpage>91</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1097/INF.0b013e31826fb32d</pub-id><?supplied-pmid 22926212?><pub-id pub-id-type="pmid">22926212</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Negi</surname><given-names>R</given-names></name><name><surname>Dewan</surname><given-names>P</given-names></name><name><surname>Shah</surname><given-names>D</given-names></name><name><surname>Das</surname><given-names>S</given-names></name><name><surname>Bhatnagar</surname><given-names>S</given-names></name><name><surname>Gupta</surname><given-names>P</given-names></name></person-group><article-title>Oral zinc supplements are ineffective for treating acute dehydrating diarrhoea in 5-12-year-olds</article-title><source>Acta Paediatr</source><year>2015</year><volume>104</volume><issue>8</issue><fpage>e367</fpage><lpage>e371</lpage><pub-id pub-id-type="doi">10.1111/apa.12645</pub-id><?supplied-pmid 24673165?><pub-id pub-id-type="pmid">24673165</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faruque</surname><given-names>AS</given-names></name><name><surname>Mahalanabis</surname><given-names>D</given-names></name><name><surname>Haque</surname><given-names>SS</given-names></name><name><surname>Fuchs</surname><given-names>GJ</given-names></name><name><surname>Habte</surname><given-names>D</given-names></name></person-group><article-title>Double-blind, randomized, controlled trial of zinc or vitamin A supplementation in young children with acute diarrhoea</article-title><source>Acta Paediatr</source><year>1999</year><volume>88</volume><fpage>154</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1111/j.1651-2227.1999.tb01074.x</pub-id><?supplied-pmid 10102147?><pub-id pub-id-type="pmid">10102147</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eichenberger</surname><given-names>JR</given-names></name><name><surname>Hadorn</surname><given-names>B</given-names></name><name><surname>Schmidt</surname><given-names>B</given-names></name></person-group><article-title>A semi-elemental diet with low osmolarity and high content of hydrolyzed lactalbumin in the treatment of acute diarrhea in malnourished children</article-title><source>Arq Gastroenterol</source><year>1984</year><volume>21</volume><fpage>130</fpage><lpage>135</lpage><?supplied-pmid 6442856?><pub-id pub-id-type="pmid">6442856</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nurko</surname><given-names>S</given-names></name><name><surname>Garc&#x000ed;a-Aranda</surname><given-names>JA</given-names></name><name><surname>Fishbein</surname><given-names>E</given-names></name><name><surname>P&#x000e9;rez-Z&#x000fa;&#x000f1;iga</surname><given-names>MI</given-names></name></person-group><article-title>Successful use of a chicken-based diet for the treatment of severely malnourished children with persistent diarrhea: a prospective, randomized study</article-title><source>J Pediatr</source><year>1997</year><volume>131</volume><fpage>405</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1016/S0022-3476(97)80066-2</pub-id><?supplied-pmid 9329417?><pub-id pub-id-type="pmid">9329417</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Mattos</surname><given-names>&#x000c2;</given-names></name><name><surname>Ribeiro</surname><given-names>T</given-names></name><name><surname>Mendes</surname><given-names>P</given-names></name><name><surname>Valois</surname><given-names>S</given-names></name><name><surname>Mendes</surname><given-names>C</given-names></name><name><surname>Ribeiro</surname><given-names>H</given-names></name></person-group><article-title>Comparison of yogurt, soybean, casein, and amino acid-based diets in children with persistent diarrhea</article-title><source>Nutr Res</source><year>2009</year><volume>29</volume><fpage>462</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1016/j.nutres.2009.06.005</pub-id><?supplied-pmid 19700033?><pub-id pub-id-type="pmid">19700033</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="other">Lozano J, Cespedes J. Lactose vs lactose free regimen in children with acute diarrhoae: a randomized controlled trial. Arch Latinoam Nutr. 1994;44</mixed-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santosham</surname><given-names>M</given-names></name><name><surname>Carrera</surname><given-names>E</given-names></name><name><surname>Sack</surname><given-names>RB</given-names></name></person-group><article-title>Oral rehydration therapy in well nourished ambulatory children</article-title><source>Am J Trop Med Hyg</source><year>1983</year><volume>32</volume><fpage>804</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1983.32.804</pub-id><?supplied-pmid 6881428?><pub-id pub-id-type="pmid">6881428</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname><given-names>HCJ</given-names></name><name><surname>Lifshitz</surname><given-names>F</given-names></name></person-group><article-title>Alanine-based oral rehydration therapy for infants with acute diarrhea</article-title><source>Pediatrics</source><year>1991</year><volume>118</volume><fpage>S86</fpage><lpage>S90</lpage><pub-id pub-id-type="doi">10.1016/S0022-3476(05)81432-5</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villarruel</surname><given-names>G</given-names></name><name><surname>Rubio</surname><given-names>DM</given-names></name><name><surname>Lopez</surname><given-names>F</given-names></name><name><surname>Cintioni</surname><given-names>J</given-names></name><name><surname>Gurevech</surname><given-names>R</given-names></name><name><surname>Romero</surname><given-names>G</given-names></name><name><surname>Vandenplas</surname><given-names>Y</given-names></name></person-group><article-title>Saccharomyces boulardii in acute childhood diarrhoea: a randomized, placebo-controlled study</article-title><source>Acta Paediatr.</source><year>2007</year><volume>96</volume><fpage>538</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1111/j.1651-2227.2007.00191.x</pub-id><?supplied-pmid 17306006?><pub-id pub-id-type="pmid">17306006</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amadi</surname><given-names>B</given-names></name><name><surname>Mwiya</surname><given-names>M</given-names></name><name><surname>Musuku</surname><given-names>J</given-names></name><name><surname>Watuka</surname><given-names>A</given-names></name><name><surname>Sianongo</surname><given-names>S</given-names></name><name><surname>Ayoub</surname><given-names>A</given-names></name><name><surname>Kelly</surname><given-names>P</given-names></name></person-group><article-title>Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial</article-title><source>Lancet</source><year>2002</year><volume>360</volume><fpage>1375</fpage><lpage>1380</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(02)11401-2</pub-id><?supplied-pmid 12423984?><pub-id pub-id-type="pmid">12423984</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valentiner-Branth</surname><given-names>P</given-names></name><name><surname>Steinsland</surname><given-names>H</given-names></name><name><surname>Santos</surname><given-names>G</given-names></name><name><surname>Perch</surname><given-names>M</given-names></name><name><surname>Begtrup</surname><given-names>K</given-names></name><name><surname>Bhan</surname><given-names>MK</given-names></name><name><surname>Dias</surname><given-names>F</given-names></name><name><surname>Aaby</surname><given-names>P</given-names></name><name><surname>Sommerfelt</surname><given-names>H</given-names></name><name><surname>M&#x000f8;lbak</surname><given-names>K</given-names></name></person-group><article-title>Community-based controlled trial of dietary management of children with persistent diarrhea: sustained beneficial effect on ponderal and linear growth</article-title><source>Am J Clin Nutr</source><year>2001</year><volume>73</volume><fpage>968</fpage><lpage>974</lpage><?supplied-pmid 11333852?><pub-id pub-id-type="pmid">11333852</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rollins</surname><given-names>NC</given-names></name><name><surname>Van Den Broeck</surname><given-names>J</given-names></name><name><surname>Kindra</surname><given-names>G</given-names></name><name><surname>Pent</surname><given-names>M</given-names></name><name><surname>Kasambira</surname><given-names>T</given-names></name><name><surname>Bennish</surname><given-names>ML</given-names></name></person-group><article-title>The effect of nutritional support on weight gain of HIV-infected children with prolonged diarrhoea</article-title><source>Acta Paediatr.</source><year>2007</year><volume>96</volume><fpage>62</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1111/j.1651-2227.2006.00013.x</pub-id><?supplied-pmid 17187606?><pub-id pub-id-type="pmid">17187606</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Kam</surname><given-names>S</given-names></name><name><surname>Roll</surname><given-names>S</given-names></name><name><surname>Swarthout</surname><given-names>T</given-names></name><name><surname>Edyegu-Otelu</surname><given-names>G</given-names></name><name><surname>Matsumoto</surname><given-names>A</given-names></name><name><surname>Kasujja</surname><given-names>FX</given-names></name><name><surname>Casademont</surname><given-names>C</given-names></name><name><surname>Shanks</surname><given-names>L</given-names></name><name><surname>Salse-Ubach</surname><given-names>N</given-names></name></person-group><article-title>Effect of short-term supplementation with ready-to-use therapeutic food or micronutrients for children after illness for prevention of malnutrition: a randomised controlled trial in Uganda</article-title><source>PLoS Med</source><year>2016</year><volume>13</volume><issue>2</issue><fpage>e1001951</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1001951</pub-id><?supplied-pmid 26859481?><pub-id pub-id-type="pmid">26859481</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Kam</surname><given-names>S</given-names></name><name><surname>Salse-Ubach</surname><given-names>N</given-names></name><name><surname>Roll</surname><given-names>S</given-names></name><name><surname>Swarthout</surname><given-names>T</given-names></name><name><surname>Gayton-Toyoshima</surname><given-names>S</given-names></name><name><surname>Jiya</surname><given-names>NM</given-names></name><name><surname>Matsumoto</surname><given-names>A</given-names></name><name><surname>Shanks</surname><given-names>L</given-names></name></person-group><article-title>Effect of short-term supplementation with ready-to-use therapeutic food or micronutrients for children after illness for prevention of malnutrition: a randomised controlled trial in Nigeria</article-title><source>PLoS Med</source><year>2016</year><volume>13</volume><issue>2</issue><fpage>e1001952</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1001952</pub-id><?supplied-pmid 26859559?><pub-id pub-id-type="pmid">26859559</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boudraa</surname><given-names>G</given-names></name><name><surname>Benbouabdellah</surname><given-names>M</given-names></name><name><surname>Hachelaf</surname><given-names>W</given-names></name><name><surname>Boisset</surname><given-names>M</given-names></name><name><surname>Desjeux</surname><given-names>JF</given-names></name><name><surname>Touhami</surname><given-names>M</given-names></name></person-group><article-title>Effect of feeding yogurt versus milk in children with acute diarrhea and carbohydrate malabsorption</article-title><source>J Pediatr Gastroenterol Nutr</source><year>2001</year><volume>33</volume><issue>3</issue><fpage>307</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1097/00005176-200109000-00015</pub-id><?supplied-pmid 11593127?><pub-id pub-id-type="pmid">11593127</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fajolu</surname><given-names>I</given-names></name><name><surname>Emokpae</surname><given-names>A</given-names></name><name><surname>Oduwole</surname><given-names>A</given-names></name><name><surname>Silva</surname><given-names>B</given-names></name><name><surname>Abidoye</surname><given-names>R</given-names></name><name><surname>Renner</surname><given-names>J</given-names></name></person-group><article-title>Zinc supplementation in children with acute diarrhoea</article-title><source>Nig. Q. J. Hosp. Med.</source><year>2008</year><volume>18</volume><fpage>101</fpage><lpage>103</lpage><?supplied-pmid 19068562?><pub-id pub-id-type="pmid">19068562</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="other">Bhutta Z, Nizami SQ, Isani Z. Zinc supplementation in malnourished children with persistent diarrhea in Pakistan. Pediatrics. 1999;103</mixed-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhutta</surname><given-names>Z</given-names></name><name><surname>Molla</surname><given-names>A</given-names></name><name><surname>Badruddin</surname><given-names>S</given-names></name></person-group><article-title>Dietary management of persistent diarrhea- comparison of a traditional rice-lentil based diet with soy formula</article-title><source>Pediatrics</source><year>1991</year><volume>88</volume><fpage>1010</fpage><lpage>1018</lpage><?supplied-pmid 1945604?><pub-id pub-id-type="pmid">1945604</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yal&#x000e7;in</surname><given-names>SS</given-names></name><name><surname>Yurdak&#x000f6;k</surname><given-names>K</given-names></name><name><surname>Tezcan</surname><given-names>I</given-names></name><name><surname>Oner</surname><given-names>L</given-names></name></person-group><article-title>Effect of glutamine supplementation on diarrhea, interleukin-8 and secretory immunoglobulin a in children with acute diarrhea</article-title><source>J Pediatr Gastroenterol Nutr</source><year>2004</year><volume>38</volume><fpage>494</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1097/00005176-200405000-00007</pub-id><?supplied-pmid 15097437?><pub-id pub-id-type="pmid">15097437</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinleyici</surname><given-names>EC</given-names></name><name><surname>Vandenplas</surname><given-names>Y</given-names></name></person-group><article-title>Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children</article-title><source>Acta Paediatr.</source><year>2014</year><volume>103</volume><fpage>300</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1111/apa.12515</pub-id><pub-id pub-id-type="pmid">24236639</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>CL</given-names></name><name><surname>Bhutta</surname><given-names>ZA</given-names></name><name><surname>Bhandari</surname><given-names>N</given-names></name><name><surname>Teka</surname><given-names>T</given-names></name><name><surname>Shahid</surname><given-names>F</given-names></name><name><surname>Taneja</surname><given-names>S</given-names></name><name><surname>Black</surname><given-names>RE</given-names></name><name><surname>Rasool</surname><given-names>S</given-names></name><name><surname>Nizami</surname><given-names>SQ</given-names></name><name><surname>Rongsen</surname><given-names>T</given-names></name><etal/></person-group><article-title>Zinc during and in convalescence from diarrhea has no demonstrable effect on subsequent morbidity and anthropometric status among infants &#x0003c;6 mo of age</article-title><source>Am J Clin Nutr</source><year>2007</year><volume>85</volume><fpage>887</fpage><lpage>894</lpage><?supplied-pmid 17344513?><pub-id pub-id-type="pmid">17344513</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sindhu</surname><given-names>KNC</given-names></name><name><surname>Sowmyanarayanan</surname><given-names>TV</given-names></name><name><surname>Paul</surname><given-names>A</given-names></name><name><surname>Babji</surname><given-names>S</given-names></name><name><surname>Ajjampur</surname><given-names>SSR</given-names></name><name><surname>Priyadarshini</surname><given-names>S</given-names></name><name><surname>Sarkar</surname><given-names>R</given-names></name><name><surname>Balasubramanian</surname><given-names>KA</given-names></name><name><surname>Wanke</surname><given-names>CA</given-names></name><name><surname>Ward</surname><given-names>HD</given-names></name><etal/></person-group><article-title>Immune response and intestinal permeability in children with acute gastroenteritis treated with lactobacillus rhamnosus GG: A randomized, double-blind, placebo-controlled trial</article-title><source>Clin Infect Dis</source><year>2014</year><volume>58</volume><fpage>1107</fpage><lpage>1115</lpage><pub-id pub-id-type="doi">10.1093/cid/ciu065</pub-id><?supplied-pmid 24501384?><pub-id pub-id-type="pmid">24501384</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>S</given-names></name><name><surname>Mushtaq</surname><given-names>M</given-names></name></person-group><article-title>Antibiotic associated diarrhea in children</article-title><source>Indian Pediatr</source><year>2009</year><volume>46</volume><issue>6</issue><fpage>491</fpage><lpage>496</lpage><?supplied-pmid 19556659?><pub-id pub-id-type="pmid">19556659</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><mixed-citation publication-type="other">Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn JE, Cousens S, Mathers C, Black RE. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet. 2014;</mixed-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotloff</surname><given-names>KL</given-names></name><name><surname>Nataro</surname><given-names>JP</given-names></name><name><surname>Blackwelder</surname><given-names>WC</given-names></name><name><surname>Nasrin</surname><given-names>D</given-names></name><name><surname>Farag</surname><given-names>TH</given-names></name><name><surname>Panchalingam</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Sow</surname><given-names>SO</given-names></name><name><surname>Sur</surname><given-names>D</given-names></name><name><surname>Breiman</surname><given-names>RF</given-names></name><etal/></person-group><article-title>Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the global enteric multicenter study, GEMS): a prospective, case-control study</article-title><source>Lancet</source><year>2013</year><volume>382</volume><issue>9888</issue><fpage>209</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(13)60844-2</pub-id><?supplied-pmid 23680352?><pub-id pub-id-type="pmid">23680352</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazzerini</surname><given-names>M</given-names></name><name><surname>Wanzira</surname><given-names>H</given-names></name></person-group><article-title>Oral zinc for treating diarrhoea in children</article-title><source>Cochrane Database Syst Rev</source><year>2016</year><volume>12</volume><fpage>CD005436</fpage><?supplied-pmid 27996088?><pub-id pub-id-type="pmid">27996088</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer Walker</surname><given-names>CL</given-names></name><name><surname>Bhutta</surname><given-names>ZA</given-names></name><name><surname>Bhandari</surname><given-names>N</given-names></name><name><surname>Teka</surname><given-names>T</given-names></name><name><surname>Shahid</surname><given-names>F</given-names></name><name><surname>Taneja</surname><given-names>S</given-names></name><name><surname>Black</surname><given-names>RE</given-names></name><name><surname>Zinc Study</surname><given-names>G</given-names></name></person-group><article-title>Zinc supplementation for the treatment of diarrhea in infants in Pakistan, India and Ethiopia</article-title><source>J Pediatr Gastroenterol Nutr</source><year>2006</year><volume>43</volume><issue>3</issue><fpage>357</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1097/01.mpg.0000232018.40907.00</pub-id><?supplied-pmid 16954960?><pub-id pub-id-type="pmid">16954960</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><mixed-citation publication-type="other">Organization WH: Pocket book of hospital care for children: guidelines for the management of common illnesses second edition. In<italic>.</italic> Geneva, Switzerland: WHO; 2013.</mixed-citation></ref><ref id="CR61"><label>61.</label><mixed-citation publication-type="other">Organization WH: Diarrhoea Treatment Guidelines. In<italic>.</italic> Geneva, Switzerland: WHO; 2005.</mixed-citation></ref><ref id="CR62"><label>62.</label><mixed-citation publication-type="other">PPernica JM, Steenhoff AP, Mokomane M, et al. Rapid enteric testing to permit targeted antimicrobial therapy, with and without Lactobacillus reuteri probiotics, for paediatric acute diarrhoeal disease in Botswana: A pilot, randomized, factorial, controlled trial. PLoS One. 2017;12:e0185177. </mixed-citation></ref><ref id="CR63"><label>63.</label><mixed-citation publication-type="other">Pavlinac PB, Denno DM, John-Stewart GC, Onchiri FM, Naulikha JM, Odundo EA, Hulseberg CE, Singa BO, Manhart LE, Walson JL. Failure of Syndrome-Based Diarrhea Management Guidelines to Detect Shigella Infections in Kenyan Children. J Pediatric Infect Dis Soc. 2016;(5, 4):366&#x02013;74.</mixed-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogawski</surname><given-names>ET</given-names></name><name><surname>Platts-Mills</surname><given-names>JA</given-names></name><name><surname>Seidman</surname><given-names>JC</given-names></name><name><surname>John</surname><given-names>S</given-names></name><name><surname>Mahfuz</surname><given-names>M</given-names></name><name><surname>Ulak</surname><given-names>M</given-names></name><name><surname>Shrestha</surname><given-names>SK</given-names></name><name><surname>Soofi</surname><given-names>SB</given-names></name><name><surname>Yori</surname><given-names>PP</given-names></name><name><surname>Mduma</surname><given-names>E</given-names></name><etal/></person-group><article-title>Use of antibiotics in children younger than two years in eight countries: a prospective cohort study</article-title><source>Bull World Health Organ</source><year>2017</year><volume>95</volume><issue>1</issue><fpage>49</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.2471/BLT.16.176123</pub-id><?supplied-pmid 28053364?><pub-id pub-id-type="pmid">28053364</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weizman</surname><given-names>Z</given-names></name><name><surname>Binsztok</surname><given-names>M</given-names></name><name><surname>Fraser</surname><given-names>D</given-names></name><name><surname>Deckelbaum</surname><given-names>RJ</given-names></name><name><surname>Granot</surname><given-names>E</given-names></name></person-group><article-title>Intestinal protein loss in acute and persistent diarrhea of early childhood</article-title><source>J Clin Gastroenterol</source><year>2002</year><volume>34</volume><issue>4</issue><fpage>427</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1097/00004836-200204000-00008</pub-id><?supplied-pmid 11907354?><pub-id pub-id-type="pmid">11907354</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarker</surname><given-names>SA</given-names></name><name><surname>Wahed</surname><given-names>MA</given-names></name><name><surname>Rahaman</surname><given-names>MM</given-names></name><name><surname>Alam</surname><given-names>AN</given-names></name><name><surname>Islam</surname><given-names>A</given-names></name><name><surname>Jahan</surname><given-names>F</given-names></name></person-group><article-title>Persistent protein losing enteropathy in post measles diarrhoea</article-title><source>Arch Dis Child</source><year>1986</year><volume>61</volume><issue>8</issue><fpage>739</fpage><lpage>743</lpage><pub-id pub-id-type="doi">10.1136/adc.61.8.739</pub-id><?supplied-pmid 3017238?><pub-id pub-id-type="pmid">3017238</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lutter</surname><given-names>CK</given-names></name><name><surname>Mora</surname><given-names>JO</given-names></name><name><surname>Habicht</surname><given-names>JP</given-names></name><name><surname>Rasmussen</surname><given-names>KM</given-names></name><name><surname>Robson</surname><given-names>DS</given-names></name><name><surname>Sellers</surname><given-names>SG</given-names></name><name><surname>Super</surname><given-names>CM</given-names></name><name><surname>Herrera</surname><given-names>MG</given-names></name></person-group><article-title>Nutritional supplementation: effects on child stunting because of diarrhea</article-title><source>Am J Clin Nutr</source><year>1989</year><volume>50</volume><issue>1</issue><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1093/ajcn/50.1.1</pub-id><?supplied-pmid 2750681?><pub-id pub-id-type="pmid">2750681</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gat-Yablonski</surname><given-names>G</given-names></name><name><surname>Phillip</surname><given-names>M</given-names></name></person-group><article-title>Nutritionally-induced catch-up growth</article-title><source>Nutrients</source><year>2015</year><volume>7</volume><issue>1</issue><fpage>517</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.3390/nu7010517</pub-id><?supplied-pmid 25594438?><pub-id pub-id-type="pmid">25594438</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soliman</surname><given-names>AT</given-names></name><name><surname>ElZalabany</surname><given-names>MM</given-names></name><name><surname>Salama</surname><given-names>M</given-names></name><name><surname>Ansari</surname><given-names>BM</given-names></name></person-group><article-title>Serum leptin concentrations during severe protein-energy malnutrition: correlation with growth parameters and endocrine function</article-title><source>Metab Clin Exp</source><year>2000</year><volume>49</volume><issue>7</issue><fpage>819</fpage><lpage>825</lpage><pub-id pub-id-type="doi">10.1053/meta.2000.6745</pub-id><?supplied-pmid 10909989?><pub-id pub-id-type="pmid">10909989</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chouraqui</surname><given-names>JP</given-names></name><name><surname>Michard-Lenoir</surname><given-names>AP</given-names></name></person-group><article-title>Feeding infants and young children with acute diarrhea</article-title><source>Arch Pediatr</source><year>2007</year><volume>14</volume><issue>Suppl 3</issue><fpage>S176</fpage><lpage>S180</lpage><pub-id pub-id-type="doi">10.1016/S0929-693X(07)80024-8</pub-id><?supplied-pmid 17961812?><pub-id pub-id-type="pmid">17961812</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berni Canani</surname><given-names>R</given-names></name><name><surname>Buccigrossi</surname><given-names>V</given-names></name><name><surname>Passariello</surname><given-names>A</given-names></name></person-group><article-title>Mechanisms of action of zinc in acute diarrhea</article-title><source>Curr Opin Gastroenterol</source><year>2011</year><volume>27</volume><issue>1</issue><fpage>8</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1097/MOG.0b013e32833fd48a</pub-id><?supplied-pmid 20856116?><pub-id pub-id-type="pmid">20856116</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bettger</surname><given-names>WJ</given-names></name><name><surname>O'Dell</surname><given-names>BL</given-names></name></person-group><article-title>A critical physiological role of zinc in the structure and function of biomembranes</article-title><source>Life Sci</source><year>1981</year><volume>28</volume><issue>13</issue><fpage>1425</fpage><lpage>1438</lpage><pub-id pub-id-type="doi">10.1016/0024-3205(81)90374-X</pub-id><?supplied-pmid 7017326?><pub-id pub-id-type="pmid">7017326</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>AN</given-names></name><name><surname>Sarker</surname><given-names>SA</given-names></name><name><surname>Wahed</surname><given-names>MA</given-names></name><name><surname>Khatun</surname><given-names>M</given-names></name><name><surname>Rahaman</surname><given-names>MM</given-names></name></person-group><article-title>Enteric protein loss and intestinal permeability changes in children during acute shigellosis and after recovery: effect of zinc supplementation</article-title><source>Gut</source><year>1994</year><volume>35</volume><issue>12</issue><fpage>1707</fpage><lpage>1711</lpage><pub-id pub-id-type="doi">10.1136/gut.35.12.1707</pub-id><?supplied-pmid 7829006?><pub-id pub-id-type="pmid">7829006</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>CD</given-names></name><name><surname>Hawkes</surname><given-names>J</given-names></name><name><surname>Graham</surname><given-names>RD</given-names></name><name><surname>Kitchen</surname><given-names>JL</given-names></name><name><surname>Symonds</surname><given-names>EL</given-names></name><name><surname>Davidson</surname><given-names>GP</given-names></name><name><surname>Butler</surname><given-names>RN</given-names></name></person-group><article-title>Zinc-fortified oral rehydration solution improved intestinal permeability and small intestinal mucosal recovery</article-title><source>Clin Pediatr (Phila)</source><year>2015</year><volume>54</volume><issue>7</issue><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1177/0009922814562665</pub-id><pub-id pub-id-type="pmid">25520366</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alverdy</surname><given-names>JA</given-names></name><name><surname>Aoys</surname><given-names>E</given-names></name><name><surname>Weiss-Carrington</surname><given-names>P</given-names></name><name><surname>Burke</surname><given-names>DA</given-names></name></person-group><article-title>The effect of glutamine-enriched TPN on gut immune cellularity</article-title><source>J Surg Res</source><year>1992</year><volume>52</volume><issue>1</issue><fpage>34</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/0022-4804(92)90275-5</pub-id><?supplied-pmid 1548865?><pub-id pub-id-type="pmid">1548865</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barber</surname><given-names>AE</given-names></name><name><surname>Jones</surname><given-names>WG</given-names><suffix>2nd</suffix></name><name><surname>Minei</surname><given-names>JP</given-names></name><name><surname>Fahey</surname><given-names>TJ</given-names><suffix>3rd</suffix></name><name><surname>Moldawer</surname><given-names>LL</given-names></name><name><surname>Rayburn</surname><given-names>JL</given-names></name><name><surname>Fischer</surname><given-names>E</given-names></name><name><surname>Keogh</surname><given-names>CV</given-names></name><name><surname>Shires</surname><given-names>GT</given-names></name><name><surname>Lowry</surname><given-names>SF</given-names></name></person-group><article-title>Harry M. Vars award. Glutamine or fiber supplementation of a defined formula diet: impact on bacterial translocation, tissue composition, and response to endotoxin</article-title><source>JPEN J Parenter Enteral Nutr</source><year>1990</year><volume>14</volume><issue>4</issue><fpage>335</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1177/0148607190014004335</pub-id><?supplied-pmid 2169535?><pub-id pub-id-type="pmid">2169535</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burke</surname><given-names>DJ</given-names></name><name><surname>Alverdy</surname><given-names>JC</given-names></name><name><surname>Aoys</surname><given-names>E</given-names></name><name><surname>Moss</surname><given-names>GS</given-names></name></person-group><article-title>Glutamine-supplemented total parenteral nutrition improves gut immune function</article-title><source>Arch Surg</source><year>1989</year><volume>124</volume><issue>12</issue><fpage>1396</fpage><lpage>1399</lpage><pub-id pub-id-type="doi">10.1001/archsurg.1989.01410120042009</pub-id><?supplied-pmid 2511819?><pub-id pub-id-type="pmid">2511819</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galvao</surname><given-names>TF</given-names></name><name><surname>Thees</surname><given-names>MF</given-names></name><name><surname>Pontes</surname><given-names>RF</given-names></name><name><surname>Silva</surname><given-names>MT</given-names></name><name><surname>Pereira</surname><given-names>MG</given-names></name></person-group><article-title>Zinc supplementation for treating diarrhea in children: a systematic review and meta-analysis</article-title><source>Rev Panam Salud Publica</source><year>2013</year><volume>33</volume><issue>5</issue><fpage>370</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1590/S1020-49892013000500009</pub-id><?supplied-pmid 23764669?><pub-id pub-id-type="pmid">23764669</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamberti</surname><given-names>LM</given-names></name><name><surname>Walker</surname><given-names>CL</given-names></name><name><surname>Chan</surname><given-names>KY</given-names></name><name><surname>Jian</surname><given-names>WY</given-names></name><name><surname>Black</surname><given-names>RE</given-names></name></person-group><article-title>Oral zinc supplementation for the treatment of acute diarrhea in children: a systematic review and meta-analysis</article-title><source>Nutrients</source><year>2013</year><volume>5</volume><issue>11</issue><fpage>4715</fpage><lpage>4740</lpage><pub-id pub-id-type="doi">10.3390/nu5114715</pub-id><?supplied-pmid 24284615?><pub-id pub-id-type="pmid">24284615</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>CL</given-names></name><name><surname>Black</surname><given-names>RE</given-names></name></person-group><article-title>Zinc for the treatment of diarrhoea: effect on diarrhoea morbidity, mortality and incidence of future episodes</article-title><source>Int J Epidemiol</source><year>2010</year><volume>39</volume><issue>Suppl 1</issue><fpage>i63</fpage><lpage>i69</lpage><pub-id pub-id-type="doi">10.1093/ije/dyq023</pub-id><?supplied-pmid 20348128?><pub-id pub-id-type="pmid">20348128</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>SJ</given-names></name><name><surname>Martinez</surname><given-names>EG</given-names></name><name><surname>Gregorio</surname><given-names>GV</given-names></name><name><surname>Dans</surname><given-names>LF</given-names></name></person-group><article-title>Probiotics for treating acute infectious diarrhoea</article-title><source>Cochrane Database Syst Rev</source><year>2010</year><volume>11</volume><fpage>CD003048</fpage></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Applegate</surname><given-names>JA</given-names></name><name><surname>Fischer Walker</surname><given-names>CL</given-names></name><name><surname>Ambikapathi</surname><given-names>R</given-names></name><name><surname>Black</surname><given-names>RE</given-names></name></person-group><article-title>Systematic review of probiotics for the treatment of community-acquired acute diarrhea in children</article-title><source>BMC Public Health</source><year>2013</year><volume>13</volume><issue>Suppl 3</issue><fpage>S16</fpage><?supplied-pmid 24564646?><pub-id pub-id-type="pmid">24564646</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guarino</surname><given-names>A</given-names></name><name><surname>Ashkenazi</surname><given-names>S</given-names></name><name><surname>Gendrel</surname><given-names>D</given-names></name><name><surname>Lo Vecchio</surname><given-names>A</given-names></name><name><surname>Shamir</surname><given-names>R</given-names></name><name><surname>Szajewska</surname><given-names>H</given-names></name></person-group><article-title>European Society for Pediatric Gastroenterology, Hepatology, and nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014</article-title><source>J Pediatr Gastroenterol Nutr</source><year>2014</year><volume>59</volume><issue>1</issue><fpage>132</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1097/MPG.0000000000000375</pub-id><?supplied-pmid 24739189?><pub-id pub-id-type="pmid">24739189</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><mixed-citation publication-type="other">Denno DM, VanBuskirk KM, Nelson ZC, Musser CA, Tarr PI.: Environmental enteric dysfunction: advancing current knowledge. St. Louis, MO: Washington University Libraries; 2016.</mixed-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collaborators</surname><given-names>GH</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Wolock</surname><given-names>TM</given-names></name><name><surname>Carter</surname><given-names>A</given-names></name><name><surname>Nguyen</surname><given-names>G</given-names></name><name><surname>Kyu</surname><given-names>HH</given-names></name><name><surname>Gakidou</surname><given-names>E</given-names></name><name><surname>Hay</surname><given-names>SI</given-names></name><name><surname>Mills</surname><given-names>EJ</given-names></name><name><surname>Trickey</surname><given-names>A</given-names></name><etal/></person-group><article-title>Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the global burden of disease study 2015</article-title><source>Lancet HIV</source><year>2016</year><volume>3</volume><issue>8</issue><fpage>e361</fpage><lpage>e387</lpage><pub-id pub-id-type="doi">10.1016/S2352-3018(16)30087-X</pub-id><pub-id pub-id-type="pmid">27470028</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavlinac</surname><given-names>PB</given-names></name><name><surname>John-Stewart</surname><given-names>GC</given-names></name><name><surname>Naulikha</surname><given-names>JM</given-names></name><name><surname>Onchiri</surname><given-names>FM</given-names></name><name><surname>Denno</surname><given-names>DM</given-names></name><name><surname>Odundo</surname><given-names>EA</given-names></name><name><surname>Singa</surname><given-names>BO</given-names></name><name><surname>Richardson</surname><given-names>BA</given-names></name><name><surname>Walson</surname><given-names>JL</given-names></name></person-group><article-title>High-risk enteric pathogens associated with HIV infection and HIV exposure in Kenyan children with acute diarrhoea</article-title><source>AIDS</source><year>2014</year><volume>28</volume><issue>15</issue><fpage>2287</fpage><lpage>2296</lpage><pub-id pub-id-type="doi">10.1097/QAD.0000000000000396</pub-id><?supplied-pmid 25028987?><pub-id pub-id-type="pmid">25028987</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mondal</surname><given-names>D</given-names></name><name><surname>Haque</surname><given-names>R</given-names></name><name><surname>Sack</surname><given-names>RB</given-names></name><name><surname>Kirkpatrick</surname><given-names>BD</given-names></name><name><surname>Petri</surname><given-names>WA</given-names><suffix>Jr</suffix></name></person-group><article-title>Attribution of malnutrition to cause-specific diarrheal illness: evidence from a prospective study of preschool children in Mirpur, Dhaka, Bangladesh</article-title><source>Am J Trop Med Hyg</source><year>2009</year><volume>80</volume><issue>5</issue><fpage>824</fpage><lpage>826</lpage><?supplied-pmid 19407131?><pub-id pub-id-type="pmid">19407131</pub-id></element-citation></ref></ref-list></back></article>